Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040139498 A1
Publication typeApplication
Application numberUS 10/758,524
Publication dateJul 15, 2004
Filing dateJan 15, 2004
Priority dateJun 8, 2000
Also published asCA2411247A1, DE60122719D1, DE60122719T2, EP1294898A2, EP1294898B1, US6713664, US20020049994, WO2001094565A2, WO2001094565A3
Publication number10758524, 758524, US 2004/0139498 A1, US 2004/139498 A1, US 20040139498 A1, US 20040139498A1, US 2004139498 A1, US 2004139498A1, US-A1-20040139498, US-A1-2004139498, US2004/0139498A1, US2004/139498A1, US20040139498 A1, US20040139498A1, US2004139498 A1, US2004139498A1
InventorsJan Jaworski, Brenda Blacklock
Original AssigneeMiami University, An Ohio Corporation
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Fatty acid elongase 3-ketoacyl CoA synthase polypeptides
US 20040139498 A1
Abstract
Elongase KCS polypeptides with altered substrate specificity and/or catalytic activity are disclosed. Such elongase KCS polypeptides are effective for producing very long chain fatty acids (VLCFA) fatty acids. Also disclosed are nucleic acids encoding elongase KCS polypeptides, and yeast and plants expressing these polypeptides.
Images(28)
Previous page
Next page
Claims(25)
What is claimed is:
1. A polypeptide comprising in the amino-terminal to carboxy-terminal direction:
(a) a first polypeptide segment, wherein said first polypeptide segment has membrane anchoring properties; joined to
(b) a second polypeptide segment having a sequence selected from the group consisting of residues 75-114 of SEQ ID NO:12 and residues 75-114 of SEQ ID NO:14; joined to
(c) a third polypeptide segment having at least 40% sequence identity to residues 115-506 of SEQ ID NO:4.
2. The polypeptide of claim 1, wherein said third polypeptide segment has at least 50% sequence identity to residues 115-506 of SEQ ID NO:4.
3. The polypeptide of claim 2, wherein said third polypeptide segment has an aspartic acid at the position corresponding to amino acid 307 of SEQ ID NO:4.
4. The polypeptide of claim 3, wherein said polypeptide has the amino acid sequence of SEQ ID NO:20.
5. The polypeptide of claim 3, wherein said polypeptide has the amino acid sequence of SEQ ID NO:22.
6. The polypeptide of claim 3, wherein said polypeptide has the amino acid sequence of SEQ ID NO:34.
7. The polypeptide of claim 3, wherein said polypeptide has the amino acid sequence of SEQ ID NO:36.
8. The polypeptide of claim 1, wherein said polypeptide catalyzes the condensation of malonyl CoA and a C18 fatty acyl substrate, leading to the synthesis of a C20 fatty acyl CoA.
9. The polypeptide of claim 8, wherein said C18 fatty acyl substrate is an oleoyl substrate.
10. The polypeptide of claim 1, wherein said polypeptide catalyzes the condensation of malonyl CoA and a C20 fatty acyl substrate, leading to the synthesis of a C22 fatty acyl CoA.
11. The polypeptide of claim 10, wherein said C20 fatty acyl substrate is an eicosenoyl substrate.
12. A nucleic acid encoding the polypeptide of claim 1.
13. A nucleic acid encoding the polypeptide of claim 2.
14. A nucleic acid encoding the polypeptide of claim 3.
15. Host cells containing a nucleic acid encoding the polypeptide of claim 1.
16. Host cells containing a nucleic acid encoding the polypeptide of claim 2.
17. Host cells containing a nucleic acid encoding the polypeptide of claim 3.
18. The host cells of claim 15, wherein said host cells are yeast cells.
19. The host cells of claim 15, wherein said host cells are plant cells.
20. A plant containing an exogenous nucleic acid encoding the polypeptide of claim 1.
21. A plant containing an exogenous nucleic acid encoding the polypeptide of claim 2.
22. A plant containing an exogenous nucleic acid encoding the polypeptide of claim 3.
23. The plant of claim 20, wherein said plant is Brassica napus.
24. The plant of claim 21, wherein said plant is Brassica napus.
25. The plant of claim 22, wherein said plant is Brassica napus.
Description
CROSS REFERENCE TO RELATED APPLICATIONS

[0001] This application claims priority under 35 U.S.C. 119(e) of U.S. provisional application serial No. 60/210,326, filed Jun. 8, 2000.

TECHNICAL FIELD

[0002] This invention relates to enzymes involved in very long chain fatty acid (VLCFA) synthesis, and more particularly to chimeras and mutants of nucleic acid sequences encoding fatty acid elongase 3-ketoacyl CoA synthase polypeptides.

BACKGROUND

[0003] Plant seeds accumulate primarily 16- and 18-carbon fatty acids (FA). Plants also synthesize very long chain fatty acids (VLCFA). VLCFAs are saturated or unsaturated monocarboxylic acids with an unbranched even-numbered carbon chain that is greater than 18 carbons in length. Very long chain fatty acids are key components of many biologically important compounds in animals, plants, and microorganisms. For example, in animals, the VLCFA arachidonic acid is a precursor to many prostaglandins. In plants, VLCFAs are major constituents of triacylglycerols in many seed oils, are essential precursors for cuticular wax production, and are utilized in the synthesis of glycosylceramides, a component of the plasma membrane. Important VLCFAs include arachidic acid (C20:0; i.e., a 20 carbon chain with no double bonds), behenic acid (C22:0), erucic acid (C22:1), and lignoceric acid (C24:1).

[0004] VLCFAs are not desirable in edible oils. Oilseeds of the Crucifereae (e.g., rapeseed) and a few other plants, however, accumulate C20 and C22 fatty acids. Although plant breeders have developed rapeseed lines that have low levels of VLCFAs for edible oil purposes, even lower levels would be desirable. On the other hand, vegetable oils having elevated levels of VLCFAs are desirable for certain industrial uses, including uses as lubricants, fuels and as a feedstock for plastics, pharmaceuticals and cosmetics.

[0005] The biosynthesis in plants of saturated fatty acids up to an 18-carbon chain occurs in the chloroplast. C2 units from acyl thioesters are linked sequentially, beginning with the condensation of acetyl Co-enzyme A (CoA) and malonyl-acyl carrier protein (malonyl-ACP) to form a C4 acyl fatty acid. This condensation reaction is catalyzed by a 3-ketoacyl synthase III (KASIII). The enzyme 3-ketoacyl synthase I (KASI) catalyzes the stepwise condensation of a fatty acyl moiety (C4 to C14) with C2 groups and malonyl-ACP to produce a 3-ketoacyl-ACP product that is 2 carbons longer than the original substrate (C6 to C16). The last condensation reaction in the chloroplast, converting C16 to C18, is catalyzed by 3-ketoacyl synthase II (KASII). 3-ketoacyl moieties are also referred to as β-ketoacyl moieties.

[0006] Each elongation cycle involves three additional enzymatic steps in addition to the condensation reaction discussed above. Briefly, the 3-ketoacyl condensation product is reduced to 3-hydroxyacyl-ACP, dehydrated to the enoyl-ACP, and reduced to an acyl-ACP. The fully reduced fatty acyl-ACP reaction product then serves as the substrate for the next cycle of elongation.

[0007] The C18:0 saturated fatty acid (stearic acid) can be desaturated to produce a C18:1 fatty acid (oleic acid), which can be transported out of the chloroplast and converted to a C18:2 fatty acid (linoleic acid) or a C18:3 fatty acid (α-linolenic acid). Stearic acid and oleic acid can also be elongated outside the chloroplast to form VLCFAs. The formation of fatty acids longer than 18 carbons depends on the activity of a fatty acid elongase complex to carry out four reactions similar to those described above for fatty acid synthesis in the chloroplast. The initial reaction is catalyzed by an elongase 3-ketoacyl CoA synthase (elongase KCS) and involves the condensation of a two carbon group from malonyl CoA with a C18:0 or C18:1 fatty acyl CoA substrate. A gene encoding an elongase KCS from Arabidopsis thaliana has been identified and designated FAE1. See, e.g., U.S. Pat. No. 6,124,524. The gene product catalyzes the condensation of oleoyl CoA and malonyl CoA, leading to the conversion of the C18 substrate to a C20:1 product, eicosenoyl CoA. Mutations have been identified in the A. thaliana FAE1 gene (see WO 96/13582). A. thaliana plants carrying a mutation in FAE1 have significant decreases in the levels of VLCFAs in seeds.

SUMMARY

[0008] Despite 85% sequence identity at the amino acid level between the Arabidopsis thaliana FAE1 polypeptide and the Brassica napus polypeptide of GenBank Accession No. AAB72178, the composition of the oil from A. thaliana and B. napus seeds suggests that the enzymes may have different substrate specificities and/or catalytic activity. VLCFAs constitute about 22% of the seed oil of A. thaliana, whereas VLCFAs constitute about 62% of the seed oil in rape. A. thaliana seed oil is primarily eicosenoic acid (about 18%), with a small amount of erucic acid and longer-chain monunusaturated fatty acids (about 2%). In contrast, rapeseed oil has a relatively small amount of eicosenoic acid (about 10%) and relatively larger amounts of erucic acid and longer-chain monunsaturates (about 52%).

[0009] The present invention provides novel polypeptides with altered elongase KCS substrate specificity and/or catalytic activity. One such novel polypeptide comprises three polypeptide segments. The amino-terminal first polypeptide segment has membrane-anchoring properties. It is joined to a second polypeptide segment whose amino acid sequence is residues 75-114 of SEQ ID NO:12 or residues 75-114 of SEQ ID NO:14, followed by a third polypeptide segment having at least 40% sequence identity to the C-terminal 392 amino acids of SEQ ID NO:4. Examples of such polypeptides have the amino acid sequences shown in SEQ ID NOS:12 and 14. The third polypeptide segment can have an aspartic acid residue at the position corresponding to amino acid 307 of SEQ ID NO:4. Examples of such polypeptides have the amino acid sequences shown in SEQ ID NOS:20, 22, 34 and 36.

[0010] Such polypeptides can catalyze the condensation of a C18 fatty acyl substrate and malonyl CoA, leading to the synthesis of a C20 fatty acyl CoA. The fatty acid substrate can be oleic acid (C18:1), in which case the product formed is eicosenoic acid (C20:1). In some instances, the fatty acid substrate is stearic acid (C18:0) and the product formed therefrom is arachidic acid (C20:0). Such polypeptides often can fuirther catalyze the condensation of malonyl CoA and a C20 fatty acyl substrate, leading to the synthesis of a C22 fatty acyl CoA. The substrate often is eicosenoic acid (C20:1) and the product is erucic acid (C22:1). The ratio of the C22 fatty acid product to the C20 fatty acid product (C22:1/C20:1) resulting from the activity of such polypeptides can be about 0.20 or greater, about 0.30 or greater, about 0.40 or greater, or about 0.50 or greater as measured in a yeast microsome assay.

[0011] The invention also features a polypeptide comprising in the amino-terminal to carboxy-terninal direction: a first polypeptide segment that has membrane anchoring properties, joined to a second polypeptide segment that has residues 75-114 of SEQ ID NO:2, which is in turn joined to a third polypeptide segment that has at least 90% sequence identity to residues 115-506 of SEQ ID NO:4. An example of such a polypeptide has the amino acid sequence of SEQ ID NO:8. Also featured is a polypeptide comprising in the amino-terminal to carboxy-terminal direction: a first polypeptide segment having at least 80% sequence identity to residues 1-74 of SEQ ID NO:2, joined to a second polypeptide segment having residues 76-114 of SEQ ID NO:4, joined to a third polypeptide segment having at least 40% sequence identity to residues 115-506 of SEQ ID NO:4. An example of such a polypeptide has the amino acid sequence of SEQ ID NO:10. In some embodiments of these polypeptides, the third segment has an aspartic acid at the position corresponding to amino acid 307 of said SEQ ID NO:4. Examples of such polypeptides have the amino acid sequences of SEQ ID NO:16 and SEQ ID NO:18.

[0012] A plant is also disclosed, comprising at least one exogenous nucleic acid encoding one or more of the novel polypeptides disclosed herein, as well as seeds having such nucleic acids.

[0013] Nucleic acid constructs of the invention comprise at least one regulatory element operably linked to the nucleic acid coding sequence for a novel polypeptide. Host cells containing such nucleic acid constructs are disclosed. Such host cells include bacterial cells, fungal cells, insect cells, plant cells and animal cells.

[0014] A method of altering very long chain fatty acids in an organism is disclosed. The method comprises introducing an exogenous nucleic acid into the organism. The nucleic acid encodes one or more of the polypeptides described herein. The nucleic acid is expressed in the organism to produce the polypeptide(s), and the very long chain fatty acid content of the organism is increased compared to the very long chain fatty acid content of a corresponding organism that lacks the exogenous nucleic acid or does not express the exogenous nucleic acid. Suitable organisms include fungi (e.g., yeast), plants, animals, insects and bacteria. Such organisms can produce a higher level of erucic acid than a corresponding organism that lacks or does not express the exogenous nucleic acid.

[0015] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. For example, the one letter and three letter abbreviations for amino acids and the one-letter abbreviations for nucleotides are commonly understood. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. In addition, the materials, methods and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control.

[0016] The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the drawings and detailed description, and from the claims.

BRIEF DESCRIPTION OF SEQUENCES

[0017] SEQ ID NO:1 is the nucleotide sequence of the Arabidopsis thaliana FAE1 gene (GenBank Accession No. U29142).

[0018] SEQ ID NO:2 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:1 (GenBank Accession No. AAA70154).

[0019] SEQ ID NO:3 is the nucleotide sequence of a Brassica napus fatty acid elongase KCS (GenBank Accession No. AF009563).

[0020] SEQ ID NO:4 is the amino acid sequence of the B. napus polypeptide encoded by SEQ ID NO:3 (GenBank Accession No. AAB72178).

[0021] SEQ ID NO:5 is the nucleotide sequence of a B. napus fatty acid elongase KCS (GenBank Accession No. U50771).

[0022] SEQ ID NO:6 is the amino acid sequence of the B. napus polypeptide encoded by SEQ ID NO:5 (GenBank Accession No. AAA96054).

[0023] SEQ ID NO:7 is a nucleotide sequence encoding a polypeptide designated At114.

[0024] SEQ ID NO:8 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:7.

[0025] SEQ ID NO:9 is a nucleotide sequence encoding a polypeptide designated At74.

[0026] SEQ ID NO:10 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:9.

[0027] SEQ ID NO:11 is a nucleotide sequence encoding a polypeptide designated At114 L91C K92R.

[0028] SEQ ID NO:12 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:11.

[0029] SEQ ID NO:13 is a nucleotide sequence encoding a polypeptide designated At114 K92R.

[0030] SEQ ID NO:14 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:13.

[0031] SEQ ID NO:15 is a nucleotide sequence encoding a polypeptide designated At114 G307D.

[0032] SEQ ID NO:16 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:15.

[0033] SEQ ID NO:17 is a nucleotide sequence encoding a polypeptide designated At74 G306D.

[0034] SEQ ID NO:18 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:17.

[0035] SEQ ID NO:19 is a nucleotide sequence encoding a polypeptide designated At114 L91C K92R G307D.

[0036] SEQ ID NO:20 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:19.

[0037] SEQ ID NO:21 is a nucleotide sequence encoding a polypeptide designated At114 K92R G307D.

[0038] SEQ ID NO:22 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:21.

[0039] SEQ ID NO:23 is a nucleotide sequence encoding a polypeptide designated At254.

[0040] SEQ ID NO:24 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:23.

[0041] SEQ ID NO:25 is a nucleotide sequence encoding a polypeptide designated At173.

[0042] SEQ ID NO:26 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:25.

[0043] SEQ ID NO:27 is a nucleotide sequence encoding a polypeptide designated Bn176.

[0044] SEQ ID NO:28 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:27.

[0045] SEQ ID NO:29 is a nucleotide sequence encoding a polypeptide designated At399.

[0046] SEQ ID NO:30 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:29.

[0047] SEQ ID NO:31 is a nucleotide sequence encoding a polypeptide designated Bn399.

[0048] SEQ ID NO:32 is the amino acid-sequence of the polypeptide encoded by SEQ ID NO:31.

[0049] SEQ ID NO:33 is a nucleotide sequence encoding a polypeptide designated Bn G307D.

[0050] SEQ ID NO:34 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:33.

[0051] SEQ ID NO:35 is a nucleotide sequence encoding a polypeptide designated At K92R.

[0052] SEQ ID NO:36 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:35.

[0053] SEQ ID NO:37 is a nucleotide sequence encoding a polypeptide designated At254 G307D.

[0054] SEQ ID NO:38 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:37.

[0055] SEQ ID NO:39 is a nucleotide sequence encoding a polypeptide designated At173 G307D.

[0056] SEQ ID NO:40 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:39.

[0057] SEQ ID NO:41 is a nucleotide sequence encoding a polypeptide designated Bn399 G307D.

[0058] SEQ ID NO:42 is the amino acid sequence of the polypeptide encoded by SEQ ID NO:41.

[0059] SEQ ID NO:43 is the 3′ chimera-specific primer used in the generation of At173.

[0060] SEQ ID NO:44 is the 5′ chimera-specific primer used in the generation of At173.

[0061] SEQ ID NO:45 is the 3′ chimera-specific primer used in the generation of At114.

[0062] SEQ ID NO:46 is the 5′ chimera-specific primer used in the generation of At114.

[0063] SEQ ID NO:47 is the 3′ chimera-specific primer used in the generation of At74.

[0064] SEQ ID NO:48 is the 5′ chimera-specific primer used in the generation of At74.

[0065] SEQ ID NO:49 is the 3′ chimera-specific primer used in the generation of At114 L91C K92R.

[0066] SEQ ID NO:50 is the 5′ chimera-specific primer used in the generation of At114 L91C K92R.

[0067] SEQ ID NO:51 is the 3′ chimera-specific primer used in the generation of At114 K92R.

[0068] SEQ ID NO:52 is the 5′ chimera-specific primer used in the generation of At114 K92R.

[0069] SEQ ID NO:53 is the 5′ universal primer used in the generation of At-Bn chimeras.

[0070] SEQ ID NO:54 is the 3′ universal primer used in the generation of At-Bn chimeras.

[0071] SEQ ID NO:55 is the 5′ universal primer used in the generation of Bn-At chimeras.

[0072] SEQ ID NO:56 is the 3′ universal primer used in the generation of Bn-At chimeras.

DESCRIPTION OF DRAWINGS

[0073]FIG. 1 shows amino acid sequences of Brassica napus (Bn) elongase KCS polypeptides, Arabidopsis thaliana FAE1 (At) and novel chimeric polypeptides and novel chimeric polypeptides containing site-directed modifications. Sequences corresponding to those derived from At FAE1 are underlined. Site-directed modifications are indicated in bold. One of the Bn elongase KCS sequences shown corresponds to GenBank Accession No., AAB72178; the other B. napus sequence shown corresponds to a second B. napus elongase KCS having GenBank Accession No. AAA96054.

[0074]FIG. 2 shows nucleotide sequences of Bn elongase KCS, At FAE1 and novel chimeric nucleic acids and novel chimeric nucleic acids containing site-directed modifications. Sequences corresponding to those derived from At FAE1 are underlined. Site-directed modifications are indicated in bold. The two Bn elongase KCS nucleic acid. sequences shown encode the two Bn polypeptides shown in FIG. 1. The GenBank Accession Numbers are AF009563 and U50771, respectively.

[0075] Like reference symbols in the various drawings indicate like elements.

DETAILED DESCRIPTION

[0076] Fatty Acid Elongase KCS Polypeptides

[0077] In one aspect, the invention provides a polypeptide containing the following segments in the amino-terminal to carboxy-terminal direction: a first polypeptide segment having membrane anchoring properties, joined to a second polypeptide segment having the amino acid sequence of residues of 75-114 of SEQ ID NO:12 or SEQ ID NO:14, joined to a third polypeptide segment having at least 40% sequence identity to the C-terminal approximately 392 amino acids of the Brassica napus elongase KCS polypeptide shown in SEQ ID NO:4. For example, polypeptides designated At114 L91C K92R (SEQ ID NO:12) and At114 K92R (SEQ ID NO:14) are provided by the present invention. The primary sequence of the novel polypeptides of the invention are identified by the source and number of amino-terminal residues (e.g., At74 polypeptides have 74 amino-terminal residues from Arabidopsis thaliana), and site-directed modifications are indicated by the original amino acid residue, the position of the modification and the new residue (e.g., polypeptides containing a K92R site-directed modification had a K at amino acid position 92 which was modified by site-directed mutagenesis of the nucleic acid to encode an R residue).

[0078] The above-described pdlypeptides include a first polypeptide segment that can serve as a membrane anchor. Such a segment has properties that result in the elongase KCS polypeptide being anchored to a membrane, such as a lipid bilayer, detergent bilayer, micelle, or cell membrane. Possession of membrane anchoring properties may be the result of the primary structure, secondary structure and/or tertiary structure of the segment. For example, the segment may contain one or more transmembrane domain(s). Alternatively, a post-translational modification of an amino acid residue within the segment can result in the polypeptide being anchored to a membrane. Suitable modifications include, but are not limited to, covalent attachment of a lipid (e.g., a glycosyl phosphatidylinositol anchor) or a carbohydrate (e.g., an oligosaccharide). See, Alberts et al., The Cell, 2nd Edition, Garland Publishing, New York, pp 284-298 and Lodish et al., Molecular Cell Biology, 3rd Edition, Scientific American Books, p. 604 and pp. 688-692. The ability of a segment to serve as a membrane anchor can be demonstrated by observing whether a polypeptide having such a segment co-purifies with a membrane fraction. Alternatively, a segment can be a membrane-anchor if, after fusing it to the second and third segments, it is shown that the polypeptide possesses elongase KCS activity in an in vitro yeast microsome assay, since elongase KCS polypeptides are active when anchored to a membrane. As another alternative, computer algorithms, such as Predict Protein or META Predict Protein (see www.emblheidelberg.de/predict-protein), can be used to predict the presence of a transmembrane domain within a segment, and hence, the ability of that polypeptide segment to serve as a membrane anchor.

[0079] Examples of polypeptide segments that can be membrane anchors include, but are not limited to, amino acids 1-74 of A. thaliana FAE1 (SEQ ID NO:2), and amino acid sequences having 40% or greater sequence identity to residues 1-74 of SEQ ID NO:2. For example, amino acids 1-75 of an elongase KCS from B. napus (GenBank Accession No. AAB72178), amino acids 1-75 of B. juncea protein (EMBL Accession No. CAA71898), amino acids 1-75 of an elongase KCS from B. napus (GenBank Accession No. AAA96054), amino acids 29-105 of a putative β-ketoacyl-CoA synthase from A. thaliana (GenBank Accession No. AAD22309) and amino acids 8-76 of a fatty acid elongase-like protein from A. thaliana (EMBL Accession No. CAB36702) have at least 40% sequence identity to SEQ ID NO:2. In some embodiments, the first polypeptide segment has at least 80% sequence identity, 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity to amino acids 1-74 of SEQ ID NO:2.

[0080] A percent identity for any subject nucleic acid or amino acid sequence (e.g., any of the fatty acid elongase chimeras described herein) relative to another “target” nucleic acid or amino acid sequence can be determined as follows. First, a target nucleic acid or amino acid sequence of the invention can be compared and aligned to a subject nucleic acid or amino acid sequence, preferably using the BLAST 2 Sequences (Bl2seq) program from the stand-alone version of BLASTZ containing BLASTN and BLASTP (e.g., version 2.0.14). The stand-alone version of BLASTZ can be obtained at <www.fr.com> or <www.ncbi.nlm.nih.gov>. Instructions explaining how to use BLASTZ, and specifically the Bl2seq program, can be found in the ‘readme’ file accompanying BLASTZ. The programs also are described in detail by Karlin et al. (Proc. Natl. Acad. Sci. USA, 87:2264 (1990) and 90:5873 (1993)) and Altschul et al. (Nucl. Acids Res., 25:3389 (1997)).

[0081] Bl2seq performs a comparison between the subject sequence and a target sequence using either the BLASTN (used to compare nucleic acid sequences) or BLASTP (used to compare amino acid sequences) algorithm. Typically, the default parameters of a BLOSUM62 scoring matrix, gap existence cost of 11, a per residue cost of 1 and a lambda ratio of 0.85 are used when performing amino acid sequence alignments. The output file contains aligned regions of homology between the target sequence and the subject sequence. Once aligned, a length is determined by counting the number of consecutive nucleotides or amino acid residues (i.e., excluding gaps) from the target sequence that align with sequence from the subject sequence starting with any matched position and ending with any other matched position. A matched position is any position where an identical nucleotide or amino acid residue is present in both the target and subject sequence. Gaps of one or more residues can be inserted into a target or subject sequence to maximize sequence alignments between structurally conserved domains (e.g., α-helices, β-sheets, and loops).

[0082] The percent identity over a particular length is determined by counting the number of matched positions over that particular length, dividing that number by the length and multiplying the resulting value by 100. For example, if (i) a 1000 nucleotide target sequence is compared to a subject nucleic acid sequence (e.g., SEQ ID NO:21), (ii) the Bl2seq program presents 200 nucleotides from the target sequence aligned with a region of the subject sequence where the first and last nucleotides of that 200 nucleotide region are matches, and (iii) the number of matches over those 200 aligned nucleotides is 180, then the 1000 nucleotide target sequence contains a length of 200 and a percent identity over that length of 90 (i.e., 180200100=90).

[0083] It will be appreciated that a nucleic acid or amino acid target sequence that aligns with a subject sequence can result in many different lengths with each length having its own percent identity. It is noted that the percent identity value can be rounded to the nearest tenth. For example, 78.11, 78.12, 78.13, and 78.14 is rounded down to 78.1, while 78.15, 78.16, 78.17, 78.18, and 78.19 is rounded up to 78.2. It is also noted that the length value will always be an integer.

[0084] Polypeptides of the invention have a second segmnent which contains amino acid residues, in particular, the amino acid residue corresponding to position 92 in SEQ ID NO:2, that affect elongase KCS substrate specificity. If the residue at position 92 is an arginine residue, the ratio of the C22:1 product to the C20:1 product is higher than the corresponding ratio observed when the residue is a lysine. Accordingly, the second segment (residues 75-114) of At114 L91C K92R and At114 K92R both possess an R at position 92. Another example of such a polypeptide has the amino acid sequence of SEQ ID NO:2, except that the lysine at amino acid residue 92 is replaced with an arginine. This polypeptide, designated At K92R, has the amino acid sequence shown in SEQ ID NO:36.

[0085] Some polypeptides of the invention have a third segment that has at least 40% sequence identity to residues 115-506 of SEQ ID NO:4, which are the carboxy-terminal 392 amino acids of the B. napus polypeptide. In some embodiments, the third polypeptide segment has at least 50% sequence identity, at least 60% sequence identity, at least 70%, 80%, 90%, 95% or 99% sequence identity to the carboxy-terminal 392 amino acids of SEQ ID NO:4.

[0086] In some embodiments, the third segment has an aspartic acid residue at the position corresponding to amino acid residue 307 of SEQ ID NO:4. An aspartic acid residue at this position is useful for increasing the catalytic activity of an elongase KCS, compared to the catalytic activity of an otherwise similar polypeptide that has a glycine at this position. For example, polypeptides designated At114 G307D, At74 G306D, At114 L91C K92R G307D, At114 K92R G307D, At254 G307D, At173 G307D, Bn G307D and Bn399 G307D have an aspartic acid residue at the position corresponding to residue 307 of SEQ ID NO:4. These polypeptides have SEQ ID NOS:16, 18, 20, 22, 38, 40, 34 and 42, respectively.

[0087] In some embodiments, the third segment contains one or more of the following groups of residues: GNTSSSS at positions corresponding to residues 423-429 of SEQ ID NO:4, HAGG(R/K)A at positions corresponding to residues 391-396 of SEQ ID NO:4, or MGCSAG at positions corresponding to residues 221-226 of SEQ ID NO:4. These groups of residues are among those that are conserved among elongase KCS polypeptides and are thus found in preferred embodiments.

[0088] Segments of a polypeptide are joined to one another by covalent bonds, typically peptide bonds. The segments can be joined directly, without any intervening residues between two segments. Alternatively, one segment can be joined indirectly to an adjacent segment by amino acid residues that are situated between the two adjacent segments and are themselves covalently joined to the adjacent segments. In some embodiments, there are one, two or three intervening amino acid residues. In other embodiments, there are four, five, six, seven, eight, nine or ten intervening residues.

[0089] A polypeptide of the invention optionally can possess additional amino acid residues at the amino-terminus or the carboxy-terminus. For example, six His-tag or FLAG™ residues may be linked to a polypeptide at the amino-terminus. See, e.g., U.S. Pat. Nos. 4,851,341 and 5,001,912. A reporter polypeptide, such as green fluorescent protein, may be fused to the carboxy-terminus. See, for example, U.S. Pat. No. 5,491,084. With respect to polypeptides, “isolated” refers to a polypeptide that constitutes the major component in a mixture of components, e.g., 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, or 95% or more by weight. Isolated polypeptides typically are obtained by purification from an organism that makes the polypeptide, although chemical synthesis is also feasible. As used herein, “enriched” refers to a polypeptide that constitutes 20-30% (by weight) of a mixture of components. Methods of polypeptide purification include, for example, chromatography or immunoaffinity techniques.

[0090] A polypeptide of the invention may be detected by sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis followed by Coomassie Blue-staining or Western blot analysis using monoclonal or polyclonal antibodies that have binding affinity for the polypeptide to be detected.

[0091] The presence of a polypeptide of the invention may often be detected by measuring elongase KCS activity. An elongase KCS can catalyze the condensation of a C18 fatty acyl substrate and malonyl CoA, leading to the formation of a C20 fatty acyl product. C18 fatty acids include C18:0 (e.g., stearic acid), C18:1 (e.g., oleic acid), C18:2 (e.g., linoleic acid), and C18:3 (e.g., α-linolenic acid). In some embodiments, an elongase KCS can catalyze the conversion of a C20 fatty acyl substrate to a C22 fatty acyl product. An example of a C20:1 fatty acyl substrate is an eicosenoyl substrate. Such a substrate can be converted to a C22:1 fatty acyl product, e.g., an erucyl product.

[0092] Some polypeptides may result in an elongase KCS that does not form reaction product(s) at a desired rate. Such elongases and their genes are useful as controls in analyses of product formation by enzymatically active elongase KCS polypeptides. Such inactive elongase KCS polypeptides and their genes can also be useful in studying the regulation (e.g., transcription, translation, and post-translational events) of genes encoding enzymatically active elongase KCS polypeptides. Such elongase KCS polypeptides can be attached to Sepharose beads and used for affinity purification of fatty acyl substrates from crude preparations. In addition, such elongase KCS polypeptides and their genes can also be useful to develop reagents for various purposes, e.g., immunological reagents to monitor expression of a elongase KCS polypeptides or nucleic acid probes or primers to monitor inheritance of a elongase KCS gene in a plant breeding program.

[0093] Products formed in plants by elongase reactions involving an elongase KCS can be subsequently used to form fatty acyl triacylglycerides (TAGs) during seed development. Alternatively, such products can be further elongated to form cuticular lipids, such as waxes.

[0094] In yet another aspect, the invention provides a polypeptide containing the following segments in the amino-terminal to carboxy-terminal direction: a first polypeptide segment having at least 80% sequence identity to the first 74 amino acids of the A. thaliana FAE1 gene product (SEQ ID NO:2), joined to a second polypeptide segment having amino acids 76-114 of SEQ ID NO:4, joined to a third polypeptide segment having at least 40% sequence identity to the C-terminal 392 amino acids of a B. napus elongase KCS (SEQ ID NO:4). An example of such a polypeptide is At74 (SEQ ID NO:10). This polypeptide possesses an R residue at position 92. Another example is At74 G306D (SEQ ID NO:18), which has a D residue at position 306.

[0095] Another novel polypeptide disclosed herein contains the following segments in the amino-terminal to carboxy-terminal direction: a first polypeptide segment having membrane anchoring properties, joined to a second polypeptide segment corresponding to amino acids 75-114 of SEQ ID NO:2, joined to a third polypeptide segment having at least 90% sequence identity to the C-terminal 392 amino acids of SEQ ID NO:4. An example of such a polypeptide is At114 (SEQ ID NO:8).

[0096] The invention also features the following polypeptide, comprising in the amino-terminal to carboxy-terminal direction: (a) a first polypeptide segment having at least 90% sequence identity to residues 1-254 of SEQ ID NO:2, joined to (b) a second polypeptide segment having the amino acid sequence of residues 255-506 of SEQ ID NO:4. An example of such a polypeptide is designated At254 and the amino acid sequence is shown in FIG. 1 and SEQ ID NO:24.

[0097] Another novel polypeptide comprises (a) a first polypeptide segment having at least 85% sequence identity to residues 1-173 of SEQ ID NO:2, joined to (b) a second polypeptide segment having the amino acid sequence of residues 174-506 of SEQ ID NO:4. An example of such a polypeptide is designated At173 and the amino acid sequence is shown in FIG. 1 and SEQ ID NO:26.

[0098] Another novel polypeptide comprises: (a) a first polypeptide segment having at least 90% sequence identity to residues 1-399 of SEQ ID NO:2, joined to (b) a second polypeptide segment having amino acid residues 400-506 of SEQ ID NO:4. An example of such a polypeptide is designated At399 and the amino acid sequence is shown in FIG. 1 and SEQ ID NO:30. Such a polypeptide can exhibit a product ratio and catalytic activity resembling that of wild-type At FAE1.

[0099] The invention also features the following polypeptide, comrprising in the amino-terminal to carboxy-terminal direction: (a) a first polypeptide segment having amino acid residues 1-176 of SEQ ID NO:4, joined to (b) a second polypeptide segment having at least 95% sequence identity to residues 177-506 of SEQ ID NO:2. An example of such a polypeptide is designated Bn176 and the amino acid sequence is shown in FIG. 1 and SEQ ID NO:28. In yeast microsome assays, the Bn176 polypeptide exhibits detectable elongase KCS catalytic activity and a C21:1/C20:1 product ratio of about 0.51.

[0100] The invention also features the following polypeptide, comprising in the amino-terminal to carboxy-terminal direction: (a) a first polypeptide segment having amino acid residues 1-399 of SEQ ID NO:4, joined to (b) a second polypeptide segment having at least 95% sequence identity to residues 400-506 of SEQ ID NO:2. An example of such a polypeptide is designated Bn399 and the amino acid sequence is shown in FIG. 1 and SEQ ID NO:32. In yeast microsome assays, the Bn399 polypeptide exhibits detectable elongase KCS catalytic activity and a C21:1/C20:1 product ratio of about 0.35.

[0101] Elongase KCS Nucleic Acids and Constructs

[0102] The present invention also includes nucleic acids encoding the above-described polypeptides. As used herein, nucleic acid refers to RNA or DNA, including cDNA, synthetic DNA or genomic DNA. The nucleic acids may be single- or double-stranded, and if single-stranded, may be either the coding or non-coding strand. As used herein with respect to nucleic acids, “isolated” refers to (i) a naturally-occurring nucleic acid encoding part or all of a polypeptide of the invention, but free of sequences, i.e., coding sequences, that normally flank one or both sides of the nucleic acid encoding polypeptide in a genome; (ii) a nucleic acid incorporated into a vector or into the genomic DNA of an organism such that the resulting molecule is not identical to any naturally-occurring vector or genomic DNA; or (iii) a cDNA, a genomic nucleic acid fragment, a fragment produced by polymerase chain reaction (PCR) or a restriction fragment. Specifically excluded from this definition are nucleic acids present in mixtures of nucleic acid molecules or cells.

[0103] Examples of such nucleic acids include those encoding polypeptides designated At114, At74, At114 L91C K92R, At114 K92R, At114 G307D, At74 G306D, At114 L91C K92R G307D, At114 K92R G307D, At254, At173, Bn176, At399, Bn399 and At K92R. These nucleic acids have SEQ ID NOS: 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31 and 35, respectively. It should be appreciated that nucleic acids having a nucleotide sequence other than the specific nucleotide sequences disclosed can still encode a polypeptide having the exemplified amino acid sequence. The degeneracy of the genetic code is well known to the art; i.e., for many amino acids, there is more than one nucleotide triplet that serves as the codon for the amino acid.

[0104] Further provided are nucleic acid constructs comprising the above-described nucleic acid coding sequences. Such constructs may be incorporated into a cloning vector. Cloning vectors suitable for use in the present invention are commercially available and used routinely by those of ordinary skill. Nucleic acid constructs of the invention may additionally comprise one or more regulatory elements operably linked to a nucleic acid coding sequence. Such regulatory elements may include promoter sequences, enhancer sequences, response elements or inducible elements that modulate expression of a nucleic acid sequence. As used herein, “operably linked” refers to positioning of a regulatory element in a construct relative to a nucleic acid coding sequence in such a way as to permit or facilitate expression of the encoded polypeptide. The choice of element(s) that may be included depends upon several factors, including, but not limited to, replication efficiency, selectability, inducibility, targeting, the level of expression desired, ease of recovery and the ability of the host to perform post-translational modifications.

[0105] The term “host” or “host cell” includes not only prokaryotes, such as E. coli, but also eukaryotes, such as fungal, insect, plant and animal cells. Animal cells include, for example, COS cells and HeLa cells. Fungal cells include yeast cells, such as Saccharomyces cereviseae cells. A host cell can be transformed or transfected with a DNA molecule (e.g., a vector) using techniques known to those of ordinary skill in this art, such as calcium phosphate or lithium acetate precipitation, electroporation, lipofection and particle bombardment. Host cells containing a vector of the present invention may be used for such purposes as propagating the vector, producing a nucleic acid (e.g., DNA, RNA, antisense RNA) or expressing a polypeptide or fragments thereof.

[0106] A nucleic acid encoding a novel polypeptide of the invention may be obtained using standard molecular biology techniques, for example, molecular cloning, DNA synthesis, and the polymerase chain reaction (PCR). PCR refers to a procedure or technique in which target nucleic acids are amplified. PCR can be used to amplify specific sequences from DNA as well as RNA, including sequences from total genomic DNA or total cellular RNA. Various PCR methods are described, for example, in PCR Primer: A Laboratory Manual, Dieffenbach, C. & Dveksler, G., Eds., Cold Spring Harbor Laboratory Press, 1995. Generally, sequence information from the ends of the region of interest or beyond is employed to design oligonucleotide primers that are identical or similar in sequence to opposite strands of the template to be amplified. Various PCR strategies are available by which site-specific nucleotide sequence modifications can be introduced into a template nucleic acid.

[0107] Nucleic acids of the present invention may be detected by methods such as ethidium bromide staining of agarose gels, Southern or Northern blot hybridization, PCR or in situ hybridizations. Hybridization typically involves Southern or Northern blotting (see, for example, sections 9.37-9.52 of Sambrook et al., 1989, “Molecular Cloning, A Laboratory Manual”, 2nd Edition, Cold Spring Harbor Press, Plainview; N.Y.). Probes should hybridize under high stringency conditions to a nucleic acid or the complement thereof. High stringency conditions can include the use of low ionic strength and high temperature washes, for example 0.015 M NaCl/0.0015 M sodium citrate (0.1 SSC), 0.1% sodium dodecyl sulfate (SDS) at 65 C. In addition, denaturing agents, such as formamide, can be employed during high stringency hybridization, e.g., 50% formamide with 0.1% bovine serum albumin/0.1% Ficoll/0.1% polyvinylpyrrolidone/50 mM sodium phosphate buffer at pH 6.5 with 750 mM NaCl, 75 mM sodium citrate at 42 C.

[0108] Transgenic Plants

[0109] The invention provides a plant containing an exogenous nucleic acid that encodes a polypeptide of the invention, e.g., nucleic acids encoding a polypeptide having an amino acid sequence as shown in SEQ ID NOS:8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, or 36.

[0110] Accordingly, a method according to the invention comprises introducing a nucleic acid construct into a plant cell and producing a plant (and progeny of such a plant) from the transformed cell. Techniques for introducing exogenous nucleic acids into monocotyledonous and dicotyledonous plants are known in the art, and include, without limitation, Agrobacterium-mediated transformation, viral vector-mediated transformation, electroporation and particle gun transformation, e.g., U.S. Pat. Nos. 5,204,253 and 6,013,863. If cell or tissue cultures are used as the recipient tissue for transformation, plants can be regenerated from transformed cultures by techniques known to those skilled in the art. Transgenic plants may be entered into a breeding program, e.g., to introduce a nucleic acid encoding a polypeptide into other lines, to transfer the nucleic acid to other species or for further selection of other desirable traits. Alternatively, transgenic plants may be propagated vegetatively for those species amenable to such techniques. Progeny includes descendants of a particular plant or plant line. Progeny of an instant plant include seeds formed on F1, F2, F3, and subsequent generation plants, or seeds formed on BC1, BC2, BC3, and subsequent generation plants. Seeds produced by a transgenic plant can be grown and then selfed (or outcrossed and selfed) to obtain seeds homozygous for the nucleic acid encoding a novel polypeptide.

[0111] In another aspect, the invention provides a method of altering very long chain fatty acids in an organism. The method involves introducing an exogenous nucleic acid into the organism. The organism may be, for example, a yeast or a plant. A nucleic acid construct of the invention can alter the levels of very long chain fatty acids in plant tissues expressing the novel polypeptide, compared to VLCFA levels in corresponding tissues from a plant, that does not contain or does not express the polypeptide. A comparison can be made, for example, between a transgenic plant of a plant line and a plant of the same line that lacks the nucleic acid construct or does not express the nucleic acid construct in that tissue. Plants having an altered VLCFA composition may be identified by techniques known to the skilled artisan, e.g., thin layer chromatographic or gas-liquid chromatographic (GLC) analysis of the appropriate plant tissue. Novel polypeptides can catalyze the conversion of oleic acid (18:1) to eicosenoic acid (20:1), and the conversion of eicosenoic acid to erucic acid (22:1). In some embodiments, the ratio of erucic acid to eicosenoic acid (22:1/20:1) is greater than or equal to 0.20, as measured in the yeast microsome assay described below.

[0112] A suitable group of plants with which to practice the invention include dicots, such as alfalfa, soybean, rapeseed (high erucic and canola), safflower, or sunflower, and monocots, such as corn, wheat, rye, barley, rice, or sorghum. Suitable rapeseed species include B. napus, B. rapa, B. juncea, and B. hirta. Additional plant species suitable for use in the present invention include Sinapsis alba, Crambe abyssinica, Limnanthes douglasii and L. alba.

[0113] Suitable tissues in which to express polynucleotides and/or polypeptides of the invention include, without limitation, seeds, stems and leaves. Seeds expressing a novel coding sequence can be used to extract an oil having elevated levels of eicosenoic acid and/or erucic acid. Leaf tissues in which a novel coding sequence can be expressed include cells and tissues of the epidermis, e.g., cells that are involved in forming trichomes. Also of interest are epidermal cells involved in forming the cuticular layer. The cuticular layer comprises various very long chain fatty acids and VLCFA derivatives such as alkanes, esters, alcohols and aldehydes. Increasing the amount of VLCFAs in epidermal cells and tissues may enhance defense mechanisms and drought tolerance of plants.

[0114] The invention will be further described in the following examples, which do not limit the scope of the invention described in the claims.

EXAMPLES Example 1 Construction and Cloning of Nucleic Acids

[0115] Nucleic acids encoding chimeric polypeptides were generated by an overlap polymerase chain reaction (PCR) strategy. Horton et al. (1989), Gene, 77:61-68 and see FIG. 1 of Ho et al. (1989), Gene, 77:51-59. Briefly, a first round of PCR products were generated in separate reactions using Arabidopsis thaliana FAE1 and Brassica napus elongase KCS nucleic acid as template. Nucleic acid sequences of the A. thaliana FAE1 and B. napus elongase KCS templates are shown in SEQ ID NO:1 and 3, respectively. The portion of each template that was amplified corresponded to the segment to be combined in a desired chimera. The amino-terminal fragment of a given chimera was amplified using a 5′ universal primer (sense) and a 3′ chimera-specific primer (anti-sense). The carboxy-terminal fragment of a given chimera was amplified with a 5′ chimera-specific primer (sense) and a 3′ universal primer (anti-sense). Universal primer sequences are shown in Table 1 and SED ID NOS:53-56. Chimera-specific primer sequences are shown in Table 2 and SEQ ID NOS:43-52. The 5′ and 3′ universal primers anneal to the 5′ and 3′ ends of the template nucleic acid, respectively, and contain BamHI and EcoRI restriction sites, respectively, for ease in subcloning into an expression vector. The 5′ chimera-specific primers are antisense to the amino-terminal template and the 3′ chimera-specific primers are antisense to the carboxy-terminal template. The 5′ and 3′ chimera-specific primers each contain an internal complementary sequence where a switch occurs from the At to Bn sequence, or alternatively, from Bn to At.

[0116] The products produced by the first round of PCR were purified, and a second round of PCR was conducted using a mixture of the products from the first round of PCR as template nucleic acid. The appropriate 5′ and 3′ universal primers were used to generate the chimeric nucleic acid product in the second round PCR. The amplified product was then digested with BamHI and EcoRI, ligated into pYES2 (Invitrogen, Carlsbad, Calif.) and transformed into E. coli. pYES2 is a yeast centromere-containing, episomal plasmid that is stably propagated in both E. coli and in yeast. Each nucleic acid was. inserted downstream of the GAL1 promoter in pYES2. The GAL1 promoter is induced in yeast when galactose is present in the medium and repressed when glucose is present in the growth medium.

[0117] Nucleic acids encoding polypeptides with site-directed alterations in the coding sequence were also prepared by overlap PCR, using 5′ and 3′ chimera-specific primers in which the internal complementary region contained the desired sequence modification.

TABLE 1
Chimera type
5′ 3′
portion portion 5′ universal primer 3′ universal primer
At Bn 5′-ggggatccatgacgtccgttaacgttaagctcc-3′ 5′-ccgaattcttaggaccgaccgttttggacac-3′
(SEQ ID NO: 53) (SEQ ID NO: 54)
Bn At 5′-ggggatccatgacgtccattaacgtaaagctcc-3 5′-ccgaattcttaggaccgaccgttttggacatgagtctt-3′
(SEQ ID NO: 55) (SEQ ID NO: 56)

[0118] Due to a degeneracy in the primer used to generate the nucleic acids encoding carboxy-terminal sequences from B. napus, the amino acid residue at the fifth to last position from the carboxy-terminus in the polypeptides designated At114, At114 L91C K92R, At114 K92R and At254 is a P and the polypeptide designated At74 is a Q at that position as indicated in FIG. 1. The polypeptides designated At173 and At399 may have a P or a Q at this position and are shown as Q in FIG. 1. A Q is found in the wild-type Bn polypeptide sequence at this position. In addition, due to PCR infidelity in the preparation of the nucleic acid encoding At114, the amino acid residue at position 439 of SEQ ID NO:8 may be an A or a T, with an A being found in the wild-type Bn sequence. In addition, PCR infidelity in the preparation of the nucleic acid encoding At114 L91C K92R resulted in the residue at position 119 being an N. Position 119 in the wild-type Bn amino acid sequence is a D. Based on the data presented below, this residue can be either a D or an N without any apparent effect on activity.

[0119] Mutagenesis was confirmed by automated DNA sequencing, and each construct was used to transform S. cerevisiae strain InvScl (Invitrogen) using a-lithium-acetate procedure (Gietz, R. and Woods, R., in Molecular Genetics of Yeast: Practical Approaches, Oxford Press, pp. 121-134 (1994)).

Example 2 Fatty Acid Elongase KCS Activity in Yeast Microsomes

[0120] Elongase KCS enzymatic activity was analyzed by preparing microsomes from transformed yeast cells and assaying these microsomes in vitro for elongase KCS activity. Transformed yeast cells were grown overnight in YPD media at 30 C. with vigorous shaking. Complete minimal uracil dropout media (cm-ura) supplemented with galactose (2% weight/volume in 40 ml) was inoculated to an OD600 of 0.002 to 0.01. Cultures were grown at 30 C. to an OD600 of approximately 1.5. to 2.0. Cells were harvested by centrifugation at 5000 g for 10 min and washed with 10 ml ice cold isolation buffer (IB), which contains 80 mM Hepes-KOH (pH 7.2), 5 mM EGTA, 5 mM EDTA, 10 mM KCl, 320 mM sucrose and 2 mM DTT). Cells were then resuspended in enough IB to fill a 1.7 ml tube containing 700 μl of 0.5 μm glass beads and yeast microsomes were isolated from the cells essentially as described in Tillman, T. & Bell, R., J. Biol. Chem. 261:9144-9149 (1986). The microsomal membrane pellet was recovered by centrifugation at 252,000 g for 60 min. Microsomal pellets were resuspended in a minimal volume of IB, and the protein concentration adjusted to 2.5 μg μl−1 by addition of IB containing 15% glycerol. Microsomes were frozen on dry ice and stored at −80 C. The protein concentration in microsomes was determined by the Bradford method (Bradford, Anal. Biochem., 72:248-54, 1976).

[0121] Elongase KCS activity was measured essentially as described in Hlousek-Radojcic, et al., Plant J. 8:803-809 (1995). Briefly, the standard elongation reaction mix contained 80 mM Hepes-KOH (pH 7.2), 20 mM MgCl2, 500 μM NADPH, 100 μM malonyl-CoA, 10 μM CoA-SH and 15 μM [14C]18:1-CoA (50 μCi μmol−1). The reaction was initiated by the addition of yeast microsomes (6 μg protein) and the mixture was incubated at 30 C., in a final reaction volume of 25 μl. Reaction time was 10 min unless indicated otherwise.

[0122] Methyl esters of the acyl-CoA elongase products were prepared by incubation with 500 μl 2% H2SO4/MeOH at 80 C. for 2 h. Extracted methyl esters were separated on reverse phase silica gel TLC plates (Analtech, Newark, Del.), quantified by phosphorimaging, and analyzed by ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, Calif.). The detection limit for each product is about 0.001 nmoles/min/mg microsomal protein, depending on the phosphorimage exposure time.

Example 3 Elongase KCS Substrate Specificity

[0123] Table 3 is a summary of elongase activity and product ratios of B. napus (Bn) and A. thaliana (At) elongase KCS nucleic acid sequences expressed in yeast and assayed as described in Example 2. Microsomes prepared from galactose-induced yeast expressing the indicated nucleic acid were assayed after 10 min for conversion of labeled oleoyl substrate to eicosenoyl product, erucyl product, and lignoceryl product. For convenience, fatty acyl substrates and products are oftentimes referred to as the acid rather than as the acyl or acyl. CoA. The ratio of 22:1 product to 20:1 product is also shown. Experiments were performed on 17 individual yeast transformants for each construct.

TABLE 31
18:1( sd) 20:1( sd) 22:1( sd) 20:1 + 22:1( sd) 22:1/20:1( sd)
B. napus elongase 45 4 3.3 0.4 1.4 0.5 4.8 0.2 0.43 0.11
KCS (SEQ ID NO: 4)
A. thaliana FAE1 29 9   6 0.8 1.2 0.2 7.1 0.9 0.20 0.04
(SEQ ID NO: 2)

[0124] Table 4 shows the ratio of 22:1/20:1 products produced by Bn, At, and various chimeric polypeptides after incubation of the microsomes with the labeled 18:1 substrate for 5, 10 or 20 min. The results shown in Table 4 represent 4 different microsome preparations from a single yeast transformant with each construct and 2-3 assays of each microsomal preparation. The At FAE1 (SEQ ID NO:2) produces about 5 times more eicosenoic acid than erucic acid. In contrast, the Bn elongase KCS (SEQ ID NO:4) produces about 2-3 times more eicosenoic acid than erucic acid. See also Table 3.

[0125] The At254, At173 and At114 polypeptides have a 22:1/20:1 product ratio that is similar to that of wild-type At FAE1, whereas the At74 polypeptide has a product ratio that is similar to that of wild-type Bn (Table 4). These results indicate that amino acids affecting product specificity are present between residues 75 and 114 of the wild-type At elongase KCS. The At74 gene product possesses the amino acid sequence of the Bn elongase KCS of SEQ ID NO:4 at positions 75 to 114, indicating that amino acids of the Bn elongase KCS that differ from the at FAE1 in this region contribute to the difference in C22:1/C20:1 product ratio.

TABLE 4
Polypeptide Assayed1
Bn At At254 At173 At114 At74 At114 L91C
Time (SEQ ID (SEQ ID (SEQ ID (SEQ ID (SEQ ID (SEQ ID K92R (SEQ
(min) NO: 4) NO: 2) NO: 24) NO: 26) NO: 8) NO: 10) ID NO: 12)
5 0.35 0.07 0.18 0.04 0.14 0.03 0.11 0.07 0.17 0.04 0.42 0.07 0.22 0.02
10 0.33 0.10 0.13 0.01 0.11 0.03 0.08 0.01 0.15 0.03 0.36 0.06 0.20 0.02
20 0.35 0.13 0.13 0.02 0.12 0.03 0.11 0.05 0.16 0.04 0.29 0.05 0.20 0.04

[0126] Site-directed modifications were made to the At114 or At74 nucleic acid sequence within the region corresponding to residues 75 to 114 in order to determine which amino acids contributed to the altered product ratio. The modified nucleic acids were made according to the overlap PCR strategy described in Example 1 and the constructs were introduced into yeast. Elongase KCS activity was measured-as described in Example 2. The results showed that changing the At114 amino acid sequence from alanine to serine and glutamine to lysine at positions 157 and 163, respectively, resulted in undetectable elongase activity. Likewise, changing serine and isoleucine at positions 93 and 95 within At74 to valine in both positions also resulted in undetectable elongase activity.

[0127] However, when the leucine and lysine residues at positions 91 and 92 within the At114 polypeptide were changed to cysteine and arginine, respectively, the C22:1/C20:1 product ratio of the resulting polypeptide, At114 L91C K92R, was shifted to more closely resemble that of the wild-type Bn polypeptide (Table 4).

[0128] Site-directed modifications were made to the At114 nucleic acid sequence to generate coding sequences for two new polypeptides, one bearing the leucine to cysteine modification and one bearing the lysine to arginine modification. These polypeptides were designated At114 L91C and At114 K92R. The nucleotide sequence of the nucleic acid encoding At114 K92R is shown in SEQ ID NO:13 and the amino acid sequence of the polypeptide is shown in SEQ ID NO:14. The two nucleic acids were introduced into yeast and the activity of each polypeptide was analyzed in yeast microsome assays. The results showed that the L to C-modified polypeptide, At114 L91C, had low but detectable catalytic activity. The K to R-modified polypeptide, At114 K92R, had a higher 22:1/20:1 ratio that approached that of wild-type Bn (Table 5). Results presented are the mean of 1 to 3 individual assays each of at least 7 separate microsomal preparations.

TABLE 5
20:1 + 22:11 (22:1/20:1)
At (SEQ ID NO: 2) 16.0 +/− 2.7  0.15 +/− 0.04
Bn (SEQ ID NO: 4) 9.8 +/− 3.2 0.32 +/− 0.07
At114 K92R (SEQ ID 5.8 +/− 3.1 0.32 +/− 0.09
NO: 14)

Example 4 Elongase KCS Catalytic Activity

[0129] Table 6 shows the results of yeast microsome assays of Bn elongase KCS, At FAE1, and various chimeric polypeptides for various incubation times. The data in Table 6 show the sum of C20:1 and C22:1 in nmole/mg protein from microsome preparations assayed 2 to 3 times each.

[0130] The results indicate that the amount of elongase KCS activity of the wild-type At FAE1 is about 1.5 to 2 times higher than that of wild-type Bh elongase KCS. The At114 polypeptide has an activity that is intermediate between the wild-type At and wild-type Bn, while the At74 polypeptide has an activity that is lower than that of wild-type Bn enzymes. These results indicate that modifying amino acid residues in the region from position 74 to 114 affects elongase activity.

[0131] The activity of the At114 L91C K92R gene product was measured in yeast microsomes and is shown in Table 6. The elongase activity of this polypeptide was higher than that of At114.

TABLE 61
At114 L91C
Time Bn At At114 At74 K92R
(min) pYES2 (SEQ ID NO: 2) (SEQ ID NO: 4) (SEQ ID NO: 8) (SEQ ID NO: 10) (SEQ ID NO: 12)
0 −2.4 2.4  2.7 1.8 2.4 1.8 1.4 1.0  2.2 0.84  2.3 1.08
5 0.24 0.6  5.1 1.6 8.7 1.2 5.9 0.6 3.2 1.1 6.5 1.0
10 0.78 0.6  7.4 1.8 12.1 0.6  8.8 0.5 4.1 0.8 9.6 1.2
20 0.96 0.6  7.8 2.1 13.7 1.8  10.1 1.2  4.4 0.8 11.5 1.1 
45 1.32 0.6  8.1 2.2 14.0 0.6  10.2 1.2  4.6 0.5 12.1 0.9 

[0132] The elongase activity of the At114 L91C and At114 K92R polypeptides were also assayed in yeast microsomes. The results indicated that the catalytic activity of the At114 L91C polypeptide was about 15-30% of the activity of At114, whereas the activity of At114 K92R was approximately the same as that of At114.

[0133] A yeast microsome assay was carried out to compare the Bn elongase KCS shown in SEQ ID NO:4 and another naturally-occurring elongase KCS from the B. napus cultivar Askari. The elongase KCS from Askari has the same sequence as that shown in SEQ ID NO:4, except for a valine at position 4 and an aspartic acid at position 307. The results indicated that the Askari elongase KCS had a higher elongase activity and a higher C22:1/C20:1 ratio that did the Bn elongase KCS of SEQ ID NO:4.

[0134] Site-directed modifications to SEQ ID NO:3 were made by the techniques described in Example 2 to generate nucleic acids encoding polypeptides Bn I4V, Bn G307D and Bn I4V G307D. The latter polypeptide has the same amino acid sequence as the naturally occurring Askari elongase KCS. After cloning and transforming of each construct into yeast as described in Example 2, microsome assays were performed. Table 7 presents the results from a single experiment in which elongase activity and product ratios for the elongase KCS constructs were measured. Assays were performed as described in Example 2. The results indicate that changing the residue at position 4 from isoleucine to valine had little or no effect on the elongase activity or the C22:1/C20:1 ratio. On the other hand, the Bn G307D polypeptide had a higher elongase activity and produced more C22:1 product than did the unmodified wild-type Bn polypeptide. The amino acid sequence of Bn G307D is shown in SEQ ID NO:34.

TABLE 71
18:1 20:1 22:1 24:1 22:1/20:1 20:1 + 22:1
Bn 47.9 5.5 1.9 0.3 0.35 7.7
Bn I4V 48.4 5.5 2.0 0.4 0.37 7.8
Bn G307D 37.2 6.7 5.4 0.7 0.80 12.7
Bn I4V G307D 41.9 6.5 4.5 0.5 0.68 11.6
B. napus (Ask) 37.6 7.7 6.7 0.8 0.86 15.2

[0135] It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.

1 56 1 1709 DNA Arabidopsis thaliana CDS (1)...(1518) 1 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc gag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctt gtg gtg agc act gag aac atc aca caa ggc 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 att tat gct gga gaa aat aga tca atg atg gtt agc aat tgc ttg ttt 816 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gcg att ttg ctc tct aac aag tcg gga gac cgg 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 aga cgg tcc aag tac aag cta gtt cac acg gtc cga acg cat act gga 912 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gat gac aag tct ttt cga tgt gtg caa caa gaa gac gat gag agc 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 ggc aaa atc gga gtt tgt ctg tca aag gac ata acc aat gtt gcg ggg 1008 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 aca aca ctt acg aaa aat ata gca aca ttg ggt ccg ttg att ctt cct 1056 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gaa aag ttt ctt ttt ttc gct acc ttc gtc gcc aag aaa ctt 1104 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 cta aag gat aaa atc aag cat tac tat gtt ccg gat ttc aag ctt gct 1152 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 gtt gac cat ttc tgt att cat gcc gga ggc aga gcc gtg atc gat gag 1200 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 cta gag aag aac tta gga cta tcg ccg atc gat gtg gag gca tct aga 1248 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt ggg aat act tca tct agc tca att tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gaa tta gca tac ata gag gca aag gga aga atg aag aaa ggg aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gct tgg cag att gct tta gga tca ggg ttt aag tgt aat agt gcg gtt 1392 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta cgc aat gtc aag gca tcg gca aat agt cct tgg caa 1440 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 cat tgc atc gat aga tat ccg gtt aaa att gat tct gat ttg tca aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 tca aag act cat gtc caa aac ggt cgg tcc taatttgatg tatctgagtg 1538 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 ccaacgttta ctttgtcttt cctttctttt attggttatg aattagatgt ttactaatgt 1598 tcctctcttt ttcgttataa ataaagaagt tcaattcttc ctatagtttc aaacgcgatt 1658 ttaagcgttt ctatttaggt ttacatgaat ttcttttaca aaccatcttt t 1709 2 506 PRT Arabidopsis thaliana 2 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 3 1524 DNA Brassica napus CDS (1)...(1521) 3 atg acg tcc att aac gta aag ctc ctt tac cat tac gtc ata acc aac 48 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 ctt ttc aac ctt tgc ttc ttt ccg tta acg gcg atc gtc gcc gga aaa 96 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 gcc tat cgg ctt acc ata gac gat ctt cac cac tta tac tat tcc tat 144 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 ctc caa cac aac ctc ata acc atc gct cca ctc ttt gcc ttc acc gtt 192 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 ttc ggt tcg gtt ctc tac atc gca acc cgg ccc aaa ccg gtt tac ctc 240 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 gtt gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc 288 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 tcc aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct 336 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 cgg aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa taa 1524 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser * 500 505 4 506 PRT Brassica napus 4 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 5 1736 DNA Brassica napus CDS (85)...(1599) 5 tagagcgtaa cggaccacaa aagaggatcc atacaaatac atctcatcgc ttccattact 60 attctccgac acacacactg agca atg acg tcc att aac gta aag ctc ctt 111 Met Thr Ser Ile Asn Val Lys Leu Leu 1 5 tac cat tac gtc ata acc aac ctt ttc aac ctt tgt ttc ttt cca tta 159 Tyr His Tyr Val Ile Thr Asn Leu Phe Asn Leu Cys Phe Phe Pro Leu 10 15 20 25 acg gcg atc gtc gcc gga aaa gcc tat ctt acc ata gac gat ctt cac 207 Thr Ala Ile Val Ala Gly Lys Ala Tyr Leu Thr Ile Asp Asp Leu His 30 35 40 cac tta tac tat tcc tat ctc caa cac aac ctc ata acc att gct cca 255 His Leu Tyr Tyr Ser Tyr Leu Gln His Asn Leu Ile Thr Ile Ala Pro 45 50 55 ctc ttg gcc ttc acc gtt ttc ggt tcg gtt ctc tac atc gca acc cgg 303 Leu Leu Ala Phe Thr Val Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg 60 65 70 ccc aaa ccg gtt tac ctc gtg gag tac tca tgc tac ctt cca cca acg 351 Pro Lys Pro Val Tyr Leu Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr 75 80 85 cat tgt aga tca agt atc tcc aag gtc atg gat atc ttt ttc caa gta 399 His Cys Arg Ser Ser Ile Ser Lys Val Met Asp Ile Phe Phe Gln Val 90 95 100 105 aga aaa gct gat cct tct cgg aac ggc acg tgc gat gac tcg tcc tgg 447 Arg Lys Ala Asp Pro Ser Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp 110 115 120 ctt gac ttc ttg agg aag att caa gaa cgt tca ggt cta ggc gat gaa 495 Leu Asp Phe Leu Arg Lys Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu 125 130 135 acc cac ggg ccc gag ggg ctg ctt cag gtc cct ccc cgg aag act ttt 543 Thr His Gly Pro Glu Gly Leu Leu Gln Val Pro Pro Arg Lys Thr Phe 140 145 150 gcg cgc gcg cgt gaa gag acg gag caa gtt atc att ggt gcg cta gaa 591 Ala Arg Ala Arg Glu Glu Thr Glu Gln Val Ile Ile Gly Ala Leu Glu 155 160 165 aat cta ttc aag aac acc aat gtt aac cct aaa gat ata ggt ata ctt 639 Asn Leu Phe Lys Asn Thr Asn Val Asn Pro Lys Asp Ile Gly Ile Leu 170 175 180 185 gtg gtg aac tca agc atg ttt aat cca act cct tcg ctc tcc gcg atg 687 Val Val Asn Ser Ser Met Phe Asn Pro Thr Pro Ser Leu Ser Ala Met 190 195 200 gtc gtt aac act ttc aag ctc cga agc aac gta aga agc ttt aac ctt 735 Val Val Asn Thr Phe Lys Leu Arg Ser Asn Val Arg Ser Phe Asn Leu 205 210 215 ggt ggc atg ggt tgt agt gcc ggc gtt ata gcc att gat cta gca aag 783 Gly Gly Met Gly Cys Ser Ala Gly Val Ile Ala Ile Asp Leu Ala Lys 220 225 230 gac ttg ttg cat gtc cat aaa aat acg tat gct ctt gtg gtg agc aca 831 Asp Leu Leu His Val His Lys Asn Thr Tyr Ala Leu Val Val Ser Thr 235 240 245 gag aac atc act tat aac att tac gct ggt gat aat agg tcc atg atg 879 Glu Asn Ile Thr Tyr Asn Ile Tyr Ala Gly Asp Asn Arg Ser Met Met 250 255 260 265 gtt tca aat tgc ttg ttc cgt gtt ggt ggg gcc gct att ttg ctc tcc 927 Val Ser Asn Cys Leu Phe Arg Val Gly Gly Ala Ala Ile Leu Leu Ser 270 275 280 aac aag cct aga gat cgt aga cgg tcc aag tac gag cta gtt cac acg 975 Asn Lys Pro Arg Asp Arg Arg Arg Ser Lys Tyr Glu Leu Val His Thr 285 290 295 gtt cga acg cat acc gga gct gac gac aag tct ttt cgt tgc gtg caa 1023 Val Arg Thr His Thr Gly Ala Asp Asp Lys Ser Phe Arg Cys Val Gln 300 305 310 caa gga gac gat gag aac ggc caa acc gga gtg agt ttg tcc aag gac 1071 Gln Gly Asp Asp Glu Asn Gly Gln Thr Gly Val Ser Leu Ser Lys Asp 315 320 325 ata acc gat gtt gct ggt cga acg gtt aag aaa aac ata gca acg ctg 1119 Ile Thr Asp Val Ala Gly Arg Thr Val Lys Lys Asn Ile Ala Thr Leu 330 335 340 345 ggt ccg ttg att ctt ccg tta agc gag aaa ctt ctt ttt ttc gtt acc 1167 Gly Pro Leu Ile Leu Pro Leu Ser Glu Lys Leu Leu Phe Phe Val Thr 350 355 360 ttc atg ggc aag aaa ctt ttc aaa gac gaa atc aaa cat tat tac gtc 1215 Phe Met Gly Lys Lys Leu Phe Lys Asp Glu Ile Lys His Tyr Tyr Val 365 370 375 ccg gac ttc aag ctt gct atc gac cat ttt tgt ata cat gcc gga ggc 1263 Pro Asp Phe Lys Leu Ala Ile Asp His Phe Cys Ile His Ala Gly Gly 380 385 390 aaa gcc gtg att gat gtg cta gag aag aac cta ggc cta gca ccg atc 1311 Lys Ala Val Ile Asp Val Leu Glu Lys Asn Leu Gly Leu Ala Pro Ile 395 400 405 gat gta gag gca tca aga tca acg tta cat aga ttt gga aac act tca 1359 Asp Val Glu Ala Ser Arg Ser Thr Leu His Arg Phe Gly Asn Thr Ser 410 415 420 425 tct agc tca ata tgg tat gag ttg gca tac ata gaa ccc aaa gga agg 1407 Ser Ser Ser Ile Trp Tyr Glu Leu Ala Tyr Ile Glu Pro Lys Gly Arg 430 435 440 atg aag aaa ggt aat aaa gtt tgg cag att gct tta ggg tca ggc ttt 1455 Met Lys Lys Gly Asn Lys Val Trp Gln Ile Ala Leu Gly Ser Gly Phe 445 450 455 aag tgt aac agt gca gtt tgg gtg gct cta aac aat gtc aaa gct tca 1503 Lys Cys Asn Ser Ala Val Trp Val Ala Leu Asn Asn Val Lys Ala Ser 460 465 470 aca aat agt cct tgg gaa cac tgc atc gac aga tac ccg gtt aaa att 1551 Thr Asn Ser Pro Trp Glu His Cys Ile Asp Arg Tyr Pro Val Lys Ile 475 480 485 gat tct gat tca ggt aag tca gag act cgt gtc cca aac ggt cgg tcc 1599 Asp Ser Asp Ser Gly Lys Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 490 495 500 505 taataaatga tgtttgctct ctttcgtttc tttttattgg ttataataat ttgatggcca 1659 cgatgtttct cttgtttgtt atgaataaag aatcccacgg tgttctagta aaaaaaaaaa 1719 aaaaaaaaaa aaaaaaa 1736 6 505 PRT Brassica napus 6 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Ile Ala Pro Leu Leu Ala Phe Thr Val Phe 50 55 60 Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu Val 65 70 75 80 Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile Ser 85 90 95 Lys Val Met Asp Ile Phe Phe Gln Val Arg Lys Ala Asp Pro Ser Arg 100 105 110 Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys Ile 115 120 125 Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly Leu 130 135 140 Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Arg Ala Arg Glu Glu Thr 145 150 155 160 Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr Asn 165 170 175 Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met Phe 180 185 190 Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys Leu 195 200 205 Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser Ala 210 215 220 Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His Lys 225 230 235 240 Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn Ile 245 250 255 Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe Arg 260 265 270 Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Arg Asp Arg Arg 275 280 285 Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly Ala 290 295 300 Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn Gly 305 310 315 320 Gln Thr Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly Arg 325 330 335 Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro Leu 340 345 350 Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu Phe 355 360 365 Lys Asp Glu Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala Ile 370 375 380 Asp His Phe Cys Ile His Ala Gly Gly Lys Ala Val Ile Asp Val Leu 385 390 395 400 Glu Lys Asn Leu Gly Leu Ala Pro Ile Asp Val Glu Ala Ser Arg Ser 405 410 415 Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr Glu 420 425 430 Leu Ala Tyr Ile Glu Pro Lys Gly Arg Met Lys Lys Gly Asn Lys Val 435 440 445 Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val Trp 450 455 460 Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu His 465 470 475 480 Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys Ser 485 490 495 Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 7 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3); designated At114 7 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat gat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa rca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Xaa Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cca aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 8 506 PRT Artificial Sequence VARIANT (0)...(0) Xaa = Ala or Thr 8 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Xaa Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 9 1518 DNA Artificial Sequence 5′ 222 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1296 bp from B. napus elongase KCS (SEQ ID NO3); designated At74 9 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aaa ccg gtt tac ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Lys Pro Val Tyr Leu Val 65 70 75 80 gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc tcc 288 Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile Ser 85 90 95 aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct cgg 336 Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser Arg 100 105 110 aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag att 384 Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys Ile 115 120 125 caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg ctg 432 Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly Leu 130 135 140 ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag acg 480 Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu Thr 145 150 155 160 gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc aac 528 Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr Asn 165 170 175 gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg ttt 576 Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met Phe 180 185 190 aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag ctc 624 Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys Leu 195 200 205 cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt gcc 672 Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser Ala 210 215 220 ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat aaa 720 Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His Lys 225 230 235 240 aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac att 768 Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn Ile 245 250 255 tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc cgt 816 Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe Arg 260 265 270 gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt aga 864 Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg Arg 275 280 285 cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga gct 912 Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly Ala 290 295 300 gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac ggc 960 Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn Gly 305 310 315 320 aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt cga 1008 Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly Arg 325 330 335 acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg tta 1056 Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro Leu 340 345 350 agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt ttc 1104 Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu Phe 355 360 365 aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct att 1152 Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala Ile 370 375 380 gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg cta 1200 Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val Leu 385 390 395 400 gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga tca 1248 Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg Ser 405 410 415 acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat gag 1296 Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr Glu 420 425 430 ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa gtt 1344 Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys Val 435 440 445 tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt tgg 1392 Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val Trp 450 455 460 gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa cac 1440 Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu His 465 470 475 480 tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag tca 1488 Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys Ser 485 490 495 gag act cgt gtc caa aac ggt cgg tcc taa 1518 Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 10 505 PRT Artificial Sequence 5′ 74 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 431 amino acids from B. napus elongase KCS (SEQ ID NO4); designated At74 10 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Lys Pro Val Tyr Leu Val 65 70 75 80 Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser Arg 100 105 110 Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys Ile 115 120 125 Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly Leu 130 135 140 Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu Thr 145 150 155 160 Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr Asn 165 170 175 Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met Phe 180 185 190 Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys Leu 195 200 205 Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser Ala 210 215 220 Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His Lys 225 230 235 240 Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn Ile 245 250 255 Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe Arg 260 265 270 Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg Arg 275 280 285 Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly Ala 290 295 300 Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn Gly 305 310 315 320 Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly Arg 325 330 335 Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro Leu 340 345 350 Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu Phe 355 360 365 Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala Ile 370 375 380 Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val Leu 385 390 395 400 Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg Ser 405 410 415 Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr Glu 420 425 430 Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys Val 435 440 445 Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val Trp 450 455 460 Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu His 465 470 475 480 Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys Ser 485 490 495 Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 11 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3) having mutations at positions 271, 272 and 275; designated At114 L91C K92R 11 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat tgc aga gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Cys Arg Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat aat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asn Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cca aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 12 506 PRT Artificial Sequence 5′ 114 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 392 amino acids from B. napus elongase KCS (SEQ ID NO4) having mutations at residues 91 and 92; designated At114 L91C K92R 12 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Cys Arg Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asn Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 13 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3), having a mutation at position 275; designated At114 K92R 13 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat ctc aga gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat gat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cca aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 14 506 PRT Artificial Sequence 5′ 114 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 392 amino acids from B. napus elongase KCS (SEQ ID NO4), having a mutation at position 92; designated At114 K92R 14 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 15 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3), having a mutation at position 920; designated At114 G307D; hypothetical 15 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat gat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 16 506 PRT Artificial Sequence 5′ 114 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 392 amino acids from B. napus elongase KCS (SEQ ID NO4) having mutation at residue 307; designated At114 G307D; hypothetical 16 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 17 1518 DNA Artificial Sequence 5′ 222 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1296 bp from B. napus elongase KCS (SEQ ID NO3) having a mutation at position 917; designated At74 G306D; hypothetical 17 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aaa ccg gtt tac ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Lys Pro Val Tyr Leu Val 65 70 75 80 gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc tcc 288 Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile Ser 85 90 95 aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct cgg 336 Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser Arg 100 105 110 aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag att 384 Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys Ile 115 120 125 caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg ctg 432 Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly Leu 130 135 140 ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag acg 480 Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu Thr 145 150 155 160 gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc aac 528 Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr Asn 165 170 175 gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg ttt 576 Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met Phe 180 185 190 aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag ctc 624 Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys Leu 195 200 205 cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt gcc 672 Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser Ala 210 215 220 ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat aaa 720 Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His Lys 225 230 235 240 aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac att 768 Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn Ile 245 250 255 tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc cgt 816 Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe Arg 260 265 270 gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt aga 864 Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg Arg 275 280 285 cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga gct 912 Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly Ala 290 295 300 gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac ggc 960 Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn Gly 305 310 315 320 aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt cga 1008 Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly Arg 325 330 335 acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg tta 1056 Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro Leu 340 345 350 agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt ttc 1104 Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu Phe 355 360 365 aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct att 1152 Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala Ile 370 375 380 gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg cta 1200 Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val Leu 385 390 395 400 gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga tca 1248 Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg Ser 405 410 415 acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat gag 1296 Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr Glu 420 425 430 ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa gtt 1344 Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys Val 435 440 445 tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt tgg 1392 Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val Trp 450 455 460 gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa cac 1440 Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu His 465 470 475 480 tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag tca 1488 Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys Ser 485 490 495 gag act cgt gtc caa aac ggt cgg tcc taa 1518 Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 18 505 PRT Artificial Sequence 5′ 74 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 431 amino acids from B. napus elongase KCS (SEQ ID NO4) having a mutation at residue 306; designated At74 G306D; hypothetical 18 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Lys Pro Val Tyr Leu Val 65 70 75 80 Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser Arg 100 105 110 Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys Ile 115 120 125 Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly Leu 130 135 140 Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu Thr 145 150 155 160 Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr Asn 165 170 175 Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met Phe 180 185 190 Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys Leu 195 200 205 Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser Ala 210 215 220 Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His Lys 225 230 235 240 Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn Ile 245 250 255 Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe Arg 260 265 270 Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg Arg 275 280 285 Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly Ala 290 295 300 Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn Gly 305 310 315 320 Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly Arg 325 330 335 Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro Leu 340 345 350 Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu Phe 355 360 365 Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala Ile 370 375 380 Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val Leu 385 390 395 400 Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg Ser 405 410 415 Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr Glu 420 425 430 Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys Val 435 440 445 Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val Trp 450 455 460 Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu His 465 470 475 480 Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys Ser 485 490 495 Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 19 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3) having mutations at positions 271, 272, 275 and 920; designated At114 L91C K92R G307D; hypothetical 19 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat tgc aga gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Cys Arg Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat aat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asn Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 20 506 PRT Artificial Sequence 5′ 114 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 392 amino acids from B. napus elongase KCS (SEQ ID NO4) having mutations at positions 91, 92 and 307; designated At114 L91C K92R G307D; hypothetical 20 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Cys Arg Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asn Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 21 1521 DNA Artificial Sequence 5′ 342 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1179 bp from B. napus elongase KCS (SEQ ID NO3) having mutations at positions 275 and 920; designated At114 K92R G307D; hypothetical 21 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tat gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt ccg cca ccg cat ctc aga gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac ggc acg tgt gat gat tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 22 506 PRT Artificial Sequence 5′ 114 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 392 amino acids from B. napus elongase KCS (SEQ ID NO4) having mutations at positions 92 and 307; designated At114 K92R G307D; hypothetical 22 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 23 1521 DNA Artificial Sequence 5′ 762 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 759 bp from B. napus elongase KCS (SEQ ID NO3); designated At254 23 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc gag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctc gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cca aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 24 506 PRT Artificial Sequence 5′ 254 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 252 amino acids from B. napus elongase KCS (SEQ ID NO4); designated At254 24 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Pro Asn Gly Arg Ser 500 505 25 1521 DNA Artificial Sequence 5′ 519 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1002 bp from B. napus elongase KCS (SEQ ID NO3); designated At173 25 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc aag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cma aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Xaa Asn Gly Arg Ser 500 505 26 506 PRT Artificial Sequence 5′ 173 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 333 amino acids from B. napus elongase KCS (SEQ ID NO4); designated At173 26 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Xaa Asn Gly Arg Ser 500 505 27 1521 DNA Artificial Sequence 5′ 528 bp from B. napus elongase KCS (SEQ ID NO3) and 3′ 993 bp from A. thaliana FAE1 (SEQ ID NO1); designated Bn176 27 atg acg tcc att aac gta aag ctc ctt tac cat tac gtc ata acc aac 48 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 ctt ttc aac ctt tgc ttc ttt ccg tta acg gcg atc gtc gcc gga aaa 96 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 gcc tat cgg ctt acc ata gac gat ctt cac cac tta tac tat tcc tat 144 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 ctc caa cac aac ctc ata acc atc gct cca ctc ttt gcc ttc acc gtt 192 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 ttc ggt tcg gtt ctc tac atc gca acc cgg ccc aaa ccg gtt tac ctc 240 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 gtt gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc 288 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 tcc aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct 336 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 cgg aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctt gtg gtg agc act gag aac atc aca caa ggc 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 att tat gct gga gaa aat aga tca atg atg gtt agc aat tgc ttg ttt 816 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gcg att ttg ctc tct aac aag tcg gga gac cgg 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 aga cgg tcc aag tac aag cta gtt cac acg gtc cga acg cat act gga 912 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gat gac aag tct ttt cga tgt gtg caa caa gaa gat gat gag agc 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 ggc aaa atc gga gtt tgt ctg tca aag gac ata acc aat gtt gcg ggg 1008 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 aca aca ctt acg aaa aat ata gca aca ttg ggt ccg ttg att ctt cct 1056 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gaa aag ttt ctt ttt ttc gct acc ttc gtc gcc aag aaa ctt 1104 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 cta aag gat aaa atc aag cat tac tat gtt ccg gat ttc aag ctt gct 1152 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 gtt gac cat ttc tgt att cat gcc gga ggc aga gcc gtg atc gat gag 1200 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 cta gag aag aac tta gga cta tcg ccg atc gat gtg gag gca tct aga 1248 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt ggg aat act tca tct agc tca att tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gaa tta gca tac ata gag gca aag gga aga atg aag aaa ggg aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gct tgg cag att gct tta gga tca ggg ttt aag tgt aat agt gcg gtt 1392 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta cgc aat gtc aag gca tcg gca aat agt cct tgg caa 1440 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 cat tgc atc gat aga tat ccg gtt aaa att gat tct gat ttg tca aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 tca aag act cat gtc caa aac ggt cgg tcc taa 1521 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 28 506 PRT Artificial Sequence 5′ 176 amino acids from B. napus elongase KCS (SEQ ID NO4) and 3′ 330 amino acids from A. thaliana FAE1 (SEQ ID NO2); designated Bn176 28 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 29 1521 DNA Artificial Sequence 5′ 1197 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 324 bp from B. napus elongase KCS (SEQ ID NO3); designated At399 29 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc gag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctt gtg gtg agc act gag aac atc aca caa ggc 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 att tat gct gga gaa aat aga tca atg atg gtt agc aat tgc ttg ttt 816 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gcg att ttg ctc tct aac aag tcg gga gac cgg 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 aga cgg tcc aag tac aag cta gtt cac acg gtc cga acg cat act gga 912 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gat gac aag tct ttt cga tgt gtg caa caa gaa gac gat gag agc 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 ggc aaa atc gga gtt tgt ctg tca aag gac ata acc aat gtt gcg ggg 1008 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 aca aca ctt acg aaa aat ata gca aca ttg ggt ccg ttg att ctt cct 1056 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gaa aag ttt ctt ttt ttc gct acc ttc gtc gcc aag aaa ctt 1104 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 cta aag gat aaa atc aag cat tac tat gtt ccg gat ttc aag ctt gct 1152 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 gtt gac cat ttc tgt att cat gcc gga ggc aga gcc gtg atc gat gtg 1200 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc cma aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Xaa Asn Gly Arg Ser 500 505 30 506 PRT Artificial Sequence 5′ 399 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 107 amino acids from B. napus elongase KCS (SEQ ID NO4); designated At399 30 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Xaa Asn Gly Arg Ser 500 505 31 1521 DNA Artificial Sequence 5′ 1197 bp from B. napus elongase KCS (SEQ ID NO3) and 3′ 324 bp from A. thaliana FAE1 (SEQ ID NO1); designated Bn399 31 atg acg tcc att aac gtt aag ctc ctt tac cat tac gtc ata acc aac 48 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 ctt ttc aac ctt tgc ttc ttt ccg tta acg gcg atc gtc gcc gga aaa 96 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 gcc tat cgg ctt acc ata gac gat ctt cac cac tta tac tat tcc tat 144 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 ctc caa cac aac ctc ata acc atc gct cca ctc ttt gcc ttc acc gtt 192 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 ttc ggt tcg gtt ctc tac atc gca acc cgg ccc aaa ccg gtt tac ctc 240 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 gtt gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc 288 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 tcc aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct 336 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 cgg aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac ggc aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg atc gat gag 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 cta gag aag aac tta gga cta tcg ccg atc gat gtg gag gca tct aga 1248 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt ggg aat act tca tct agc tca att tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gaa tta gca tac ata gag gca aag gga aga atg aag aaa ggg aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gct tgg cag att gct tta gga tca ggg ttt aag tgt aat agt gcg gtt 1392 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta cgc aat gtc aag gca tcg gca aat agt cct tgg caa 1440 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 cat tgc atc gat aga tat ccg gtt aaa att gat tct gat ttg tca aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 tca aag act cat gtc caa aac ggt cgg tcc taa 1521 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 32 506 PRT Artificial Sequence 5′ 399 amino acids from B. napus elongase KCS (SEQ ID NO3) and 3′ 107 amino acids from A. thaliana FAE1 (SEQ ID NO1); designated Bn399 32 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Gly Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 33 1524 DNA Artificial Sequence 1524 bp from B. napus elongase KCS (SEQ ID NO3) having a mutation at position 920; designated Bn G307D; hypothetical 33 atg acg tcc att aac gta aag ctc ctt tac cat tac gtc ata acc aac 48 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 ctt ttc aac ctt tgc ttc ttt ccg tta acg gcg atc gtc gcc gga aaa 96 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 gcc tat cgg ctt acc ata gac gat ctt cac cac tta tac tat tcc tat 144 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 ctc caa cac aac ctc ata acc atc gct cca ctc ttt gcc ttc acc gtt 192 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 ttc ggt tcg gtt ctc tac atc gca acc cgg ccc aaa ccg gtt tac ctc 240 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 gtt gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc 288 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 tcc aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct 336 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 cgg aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taataa 1524 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 34 506 PRT Artificial Sequence 506 amino acids from B. napus elongase KCS (SEQ ID NO4) having a mutation at residue 307; designated Bn G307D; hypothetical 34 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 35 1709 DNA Artificial Sequence 1709 bp from A. thaliana FAE1 (SEQ ID NO1) having a mutation at position 275; designated At K92R; hypothetical 35 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aga gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc gag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctt gtg gtg agc act gag aac atc aca caa ggc 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 att tat gct gga gaa aat aga tca atg atg gtt agc aat tgc ttg ttt 816 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gcg att ttg ctc tct aac aag tcg gga gac cgg 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 aga cgg tcc aag tac aag cta gtt cac acg gtc cga acg cat act gga 912 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gat gac aag tct ttt cga tgt gtg caa caa gaa gac gat gag agc 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 ggc aaa atc gga gtt tgt ctg tca aag gac ata acc aat gtt gcg ggg 1008 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 aca aca ctt acg aaa aat ata gca aca ttg ggt ccg ttg att ctt cct 1056 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gaa aag ttt ctt ttt ttc gct acc ttc gtc gcc aag aaa ctt 1104 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 cta aag gat aaa atc aag cat tac tat gtt ccg gat ttc aag ctt gct 1152 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 gtt gac cat ttc tgt att cat gcc gga ggc aga gcc gtg atc gat gag 1200 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 cta gag aag aac tta gga cta tcg ccg atc gat gtg gag gca tct aga 1248 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt ggg aat act tca tct agc tca att tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gaa tta gca tac ata gag gca aag gga aga atg aag aaa ggg aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gct tgg cag att gct tta gga tca ggg ttt aag tgt aat agt gcg gtt 1392 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta cgc aat gtc aag gca tcg gca aat agt cct tgg caa 1440 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 cat tgc atc gat aga tat ccg gtt aaa att gat tct gat ttg tca aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 tca aag act cat gtc caa aac ggt cgg tcc taatttgatg tatctgagtg 1538 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 ccaacgttta ctttgtcttt cctttctttt attggttatg aattagatgt ttactaatgt 1598 tcctctcttt ttcgttataa ataaagaagt tcaattcttc ctatagtttc aaacgcgatt 1658 ttaagcgttt ctatttaggt ttacatgaat ttcttttaca aaccatcttt t 1709 36 506 PRT Artificial Sequence 506 amino acids from A. thaliana FAE1 (SEQ ID NO2) having a mutation at residue 92; designated At K92R; hypothetical 36 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Arg Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Gln Gly 245 250 255 Ile Tyr Ala Gly Glu Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Ser Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Lys Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Glu Asp Asp Glu Ser 305 310 315 320 Gly Lys Ile Gly Val Cys Leu Ser Lys Asp Ile Thr Asn Val Ala Gly 325 330 335 Thr Thr Leu Thr Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Phe Leu Phe Phe Ala Thr Phe Val Ala Lys Lys Leu 355 360 365 Leu Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Val Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 37 1521 DNA Artificial Sequence 5′ 762 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 759 bp from B. napus elongase KCS (SEQ ID NO3) and having a mutation at position 920; designated At254 G307D; hypothetical 37 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc gag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 aaa gtt aac cct aga gag att ggt ata ctt gtg gtg aac tca agc atg 576 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cct tcg cta tcc gct atg gtc gtt aat act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac atc aaa agc ttt aat cta gga gga atg ggt tgt agt 672 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gct ggt gtt att gcc att gat ttg gct aaa gac ttg ttg cat gtt cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aac act tat gct ctc gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 38 506 PRT Artificial Sequence 5′ 254 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 252 amino acids from B. napus elongase KCS (SEQ ID NO4) having a mutation at residue 307; designated At254 G307D; hypothetical 38 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Glu Asn Thr 165 170 175 Lys Val Asn Pro Arg Glu Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Ile Lys Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 39 1521 DNA Artificial Sequence 5′ 519 bp from A. thaliana FAE1 (SEQ ID NO1) and 3′ 1002 bp from B. napus elongase KCS (SEQ ID NO3) and having a mutation at position 920; designated At173 G307D 39 atg acg tcc gtt aac gtt aag ctc ctt tac cgt tac gtc tta acc aac 48 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 ttt ttc aac ctc tgt ttg ttc ccg tta acg gcg ttc ctc gcc gga aaa 96 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 gcc tct cgg ctt acc ata aac gat ctc cac aac ttc ctt tcc tat ctc 144 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 caa cac aac ctt ata aca gta act tta ctc ttt gct ttc act gtt ttc 192 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 ggt ttg gtt ctc tac atc gta acc cga ccc aat ccg gtt tat ctc gtt 240 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 gac tac tcg tgt tac ctt cca cca ccg cat ctc aaa gtt agt gtc tct 288 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 aaa gtc atg gat att ttc tac caa ata aga aaa gct gat act tct tca 336 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 cgg aac gtg gca tgt gat gat ccg tcc tcg ctc gat ttc ctg agg aag 384 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 att caa gag cgt tca ggt cta ggt gat gag acg tac agt cct gag gga 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 ctc att cac gta cca ccg cgg aag act ttt gca gcg tca cgt gaa gag 480 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 aca gag aag gtt atc atc ggt gcg ctc gaa aat cta ttc aag aac acc 528 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg att gat gtg 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 cta gag aag aac cta gcc cta gca ccg atc gat gta gag gca tca aga 1248 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt gga aac act tca tct agc tca ata tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gag ttg gca tac ata gaa gca aaa gga agg atg aag aaa ggt aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gtt tgg cag att gct tta ggg tca ggc ttt aag tgt aac agt gca gtt 1392 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta aac aat gtc aaa gct tcg aca aat agt cct tgg gaa 1440 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 cac tgc atc gac aga tac ccg gtc aaa att gat tct gat tca ggt aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 tca gag act cgt gtc caa aac ggt cgg tcc taa 1521 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 40 506 PRT Artificial Sequence 5′ 173 amino acids from A. thaliana FAE1 (SEQ ID NO2) and 3′ 333 amino acids from B. napus elongase KCS (SEQ ID NO4) having a mutation at residue 307; designated At173 G307D; hypothetical 40 Met Thr Ser Val Asn Val Lys Leu Leu Tyr Arg Tyr Val Leu Thr Asn 1 5 10 15 Phe Phe Asn Leu Cys Leu Phe Pro Leu Thr Ala Phe Leu Ala Gly Lys 20 25 30 Ala Ser Arg Leu Thr Ile Asn Asp Leu His Asn Phe Leu Ser Tyr Leu 35 40 45 Gln His Asn Leu Ile Thr Val Thr Leu Leu Phe Ala Phe Thr Val Phe 50 55 60 Gly Leu Val Leu Tyr Ile Val Thr Arg Pro Asn Pro Val Tyr Leu Val 65 70 75 80 Asp Tyr Ser Cys Tyr Leu Pro Pro Pro His Leu Lys Val Ser Val Ser 85 90 95 Lys Val Met Asp Ile Phe Tyr Gln Ile Arg Lys Ala Asp Thr Ser Ser 100 105 110 Arg Asn Val Ala Cys Asp Asp Pro Ser Ser Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr Tyr Ser Pro Glu Gly 130 135 140 Leu Ile His Val Pro Pro Arg Lys Thr Phe Ala Ala Ser Arg Glu Glu 145 150 155 160 Thr Glu Lys Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Val 385 390 395 400 Leu Glu Lys Asn Leu Ala Leu Ala Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Val Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Asn Asn Val Lys Ala Ser Thr Asn Ser Pro Trp Glu 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Ser Gly Lys 485 490 495 Ser Glu Thr Arg Val Gln Asn Gly Arg Ser 500 505 41 1521 DNA Artificial Sequence 5′ 1197 bp from B. napus elongase KCS (SEQ ID NO3) and 3′ 324 bp from A. thaliana FAE1 (SEQ ID NO1) and having a mutation at nucleotide position 920; designated Bn399 G307D; hypothetical 41 atg acg tcc att aac gtt aag ctc ctt tac cat tac gtc ata acc aac 48 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 ctt ttc aac ctt tgc ttc ttt ccg tta acg gcg atc gtc gcc gga aaa 96 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 gcc tat cgg ctt acc ata gac gat ctt cac cac tta tac tat tcc tat 144 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 ctc caa cac aac ctc ata acc atc gct cca ctc ttt gcc ttc acc gtt 192 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 ttc ggt tcg gtt ctc tac atc gca acc cgg ccc aaa ccg gtt tac ctc 240 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 gtt gag tac tca tgc tac ctt cca cca acg cat tgt aga tca agt atc 288 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 tcc aag gtc atg gat atc ttt tat caa gta aga aaa gct gat cct tct 336 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 cgg aac ggc acg tgc gat gac tcg tcg tgg ctt gac ttc ttg agg aag 384 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 att caa gaa cgt tca ggt cta ggc gat gaa act cac ggg ccc gag ggg 432 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 ctg ctt cag gtc cct ccc cgg aag act ttt gcg gcg gcg cgt gaa gag 480 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 acg gag caa gtt atc att ggt gcg cta gaa aat cta ttc aag aac acc 528 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 aac gtt aac cct aaa gat ata ggt ata ctt gtg gtg aac tca agc atg 576 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 ttt aat cca act cca tcg ctc tcc gcg atg gtc gtt aac act ttc aag 624 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 ctc cga agc aac gta aga agc ttt aac ctt ggt ggc atg ggt tgt agt 672 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 gcc ggc gtt ata gcc att gat cta gca aag gac ttg ttg cat gtc cat 720 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 aaa aat acg tat gct ctt gtg gtg agc aca gag aac atc act tat aac 768 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 att tac gct ggt gat aat agg tcc atg atg gtt tca aat tgc ttg ttc 816 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 cgt gtt ggt ggg gcc gct att ttg ctc tcc aac aag cct gga gat cgt 864 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 aga cgg tcc aag tac gag cta gtt cac acg gtt cga acg cat acc gga 912 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 gct gac gac aag tct ttt cgt tgc gtg caa caa gga gac gat gag aac 960 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 ggc aaa atc gga gtg agt ttg tcc aag gac ata acc gat gtt gct ggt 1008 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 cga acg gtt aag aaa aac ata gca acg ttg ggt ccg ttg att ctt ccg 1056 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 tta agc gag aaa ctt ctt ttt ttc gtt acc ttc atg ggc aag aaa ctt 1104 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 ttc aaa gat aaa atc aaa cat tac tac gtc ccg gat ttc aaa ctt gct 1152 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 att gac cat ttt tgt ata cat gcc gga ggc aga gcc gtg atc gat gag 1200 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 cta gag aag aac tta gga cta tcg ccg atc gat gtg gag gca tct aga 1248 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 tca acg tta cat aga ttt ggg aat act tca tct agc tca att tgg tat 1296 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 gaa tta gca tac ata gag gca aag gga aga atg aag aaa ggg aat aaa 1344 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 gct tgg cag att gct tta gga tca ggg ttt aag tgt aat agt gcg gtt 1392 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 tgg gtg gct cta cgc aat gtc aag gca tcg gca aat agt cct tgg caa 1440 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 cat tgc atc gat aga tat ccg gtt aaa att gat tct gat ttg tca aag 1488 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 tca aag act cat gtc caa aac ggt cgg tcc taa 1521 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 42 506 PRT Artificial Sequence 5′ 399 amino acids from B. napus elongase KCS (SEQ ID NO3) and 3′ 107 amino acids from A. thaliana FAE1 (SEQ ID NO1) having a mutation at residue 306; designated Bn399 G307D; hypothetical 42 Met Thr Ser Ile Asn Val Lys Leu Leu Tyr His Tyr Val Ile Thr Asn 1 5 10 15 Leu Phe Asn Leu Cys Phe Phe Pro Leu Thr Ala Ile Val Ala Gly Lys 20 25 30 Ala Tyr Arg Leu Thr Ile Asp Asp Leu His His Leu Tyr Tyr Ser Tyr 35 40 45 Leu Gln His Asn Leu Ile Thr Ile Ala Pro Leu Phe Ala Phe Thr Val 50 55 60 Phe Gly Ser Val Leu Tyr Ile Ala Thr Arg Pro Lys Pro Val Tyr Leu 65 70 75 80 Val Glu Tyr Ser Cys Tyr Leu Pro Pro Thr His Cys Arg Ser Ser Ile 85 90 95 Ser Lys Val Met Asp Ile Phe Tyr Gln Val Arg Lys Ala Asp Pro Ser 100 105 110 Arg Asn Gly Thr Cys Asp Asp Ser Ser Trp Leu Asp Phe Leu Arg Lys 115 120 125 Ile Gln Glu Arg Ser Gly Leu Gly Asp Glu Thr His Gly Pro Glu Gly 130 135 140 Leu Leu Gln Val Pro Pro Arg Lys Thr Phe Ala Ala Ala Arg Glu Glu 145 150 155 160 Thr Glu Gln Val Ile Ile Gly Ala Leu Glu Asn Leu Phe Lys Asn Thr 165 170 175 Asn Val Asn Pro Lys Asp Ile Gly Ile Leu Val Val Asn Ser Ser Met 180 185 190 Phe Asn Pro Thr Pro Ser Leu Ser Ala Met Val Val Asn Thr Phe Lys 195 200 205 Leu Arg Ser Asn Val Arg Ser Phe Asn Leu Gly Gly Met Gly Cys Ser 210 215 220 Ala Gly Val Ile Ala Ile Asp Leu Ala Lys Asp Leu Leu His Val His 225 230 235 240 Lys Asn Thr Tyr Ala Leu Val Val Ser Thr Glu Asn Ile Thr Tyr Asn 245 250 255 Ile Tyr Ala Gly Asp Asn Arg Ser Met Met Val Ser Asn Cys Leu Phe 260 265 270 Arg Val Gly Gly Ala Ala Ile Leu Leu Ser Asn Lys Pro Gly Asp Arg 275 280 285 Arg Arg Ser Lys Tyr Glu Leu Val His Thr Val Arg Thr His Thr Gly 290 295 300 Ala Asp Asp Lys Ser Phe Arg Cys Val Gln Gln Gly Asp Asp Glu Asn 305 310 315 320 Gly Lys Ile Gly Val Ser Leu Ser Lys Asp Ile Thr Asp Val Ala Gly 325 330 335 Arg Thr Val Lys Lys Asn Ile Ala Thr Leu Gly Pro Leu Ile Leu Pro 340 345 350 Leu Ser Glu Lys Leu Leu Phe Phe Val Thr Phe Met Gly Lys Lys Leu 355 360 365 Phe Lys Asp Lys Ile Lys His Tyr Tyr Val Pro Asp Phe Lys Leu Ala 370 375 380 Ile Asp His Phe Cys Ile His Ala Gly Gly Arg Ala Val Ile Asp Glu 385 390 395 400 Leu Glu Lys Asn Leu Gly Leu Ser Pro Ile Asp Val Glu Ala Ser Arg 405 410 415 Ser Thr Leu His Arg Phe Gly Asn Thr Ser Ser Ser Ser Ile Trp Tyr 420 425 430 Glu Leu Ala Tyr Ile Glu Ala Lys Gly Arg Met Lys Lys Gly Asn Lys 435 440 445 Ala Trp Gln Ile Ala Leu Gly Ser Gly Phe Lys Cys Asn Ser Ala Val 450 455 460 Trp Val Ala Leu Arg Asn Val Lys Ala Ser Ala Asn Ser Pro Trp Gln 465 470 475 480 His Cys Ile Asp Arg Tyr Pro Val Lys Ile Asp Ser Asp Leu Ser Lys 485 490 495 Ser Lys Thr His Val Gln Asn Gly Arg Ser 500 505 43 25 DNA Artificial Sequence primer for PCR 43 gcgctcgaaa atctattcaa gaaca 25 44 33 DNA Artificial Sequence primer for PCR 44 gttcttgaat agattttcga gcgcaccgat gat 33 45 28 DNA Artificial Sequence primer for PCR 45 cggaacggca cgtgtgatga ttcgtcct 28 46 28 DNA Artificial Sequence primer for PCR 46 aggacggatc atcacacgcg acgttccg 28 47 23 DNA Artificial Sequence primer for PCR 47 cccaaaccgg tttacctcgt tga 23 48 23 DNA Artificial Sequence primer for PCR 48 tcaacgaggt aaaccggatt ggg 23 49 27 DNA Artificial Sequence primer for PCR 49 ccgcattgca gagttagtgt ctctaaa 27 50 27 DNA Artificial Sequence primer for PCR 50 tttagagaca ctaactctgc aatgcgg 27 51 27 DNA Artificial Sequence primer for PCR 51 ccaccgcatc tcagagttag tgtctct 27 52 27 DNA Artificial Sequence primer for PCR 52 agagacacta actctgagat gcggtgg 27 53 33 DNA Artificial Sequence primer for PCR 53 ggggatccat gacgtccgtt aacgttaagc tcc 33 54 31 DNA Artificial Sequence primer for PCR 54 ccgaattctt aggaccgacc gttttggaca c 31 55 33 DNA Artificial Sequence primer for PCR 55 ggggatccat gacgtccatt aacgtaaagc tcc 33 56 38 DNA Artificial Sequence primer for PCR 56 ccgaattctt aggaccgacc gttttggaca tgagtctt 38

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7560539Jul 23, 2007Jul 14, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7563603Jul 16, 2007Jul 21, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7563604Jul 16, 2007Jul 21, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7563605Jul 16, 2007Jul 21, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7601522Mar 21, 2007Oct 13, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7605245Jul 12, 2007Oct 20, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7608702Mar 22, 2007Oct 27, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7608703Mar 22, 2007Oct 27, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7608753Jul 16, 2007Oct 27, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7611874Jul 16, 2007Nov 3, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7611875Jul 16, 2007Nov 3, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7611876Jul 16, 2007Nov 3, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7626009Mar 21, 2007Dec 1, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7629450Jul 23, 2007Dec 8, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7638315Jul 16, 2007Dec 29, 2009Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7642074Feb 20, 2007Jan 5, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7645597Jul 16, 2007Jan 12, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7645598Jul 16, 2007Jan 12, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7662597Jul 16, 2007Feb 16, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7718431Jul 23, 2007May 18, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7759548Mar 15, 2007Jul 20, 2010Martek Biosciences CorporationPolyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems
US7799564Jul 23, 2007Sep 21, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7803620Mar 21, 2007Sep 28, 2010Martek Biosciences CorporationPufa polyketide synthase systems and uses thereof
US7807442Jul 12, 2007Oct 5, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7816504Mar 22, 2007Oct 19, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7816505Jul 16, 2007Oct 19, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7838649Jul 16, 2007Nov 23, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7842796Mar 22, 2007Nov 30, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7847077Jul 16, 2007Dec 7, 2010Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7879608Jul 23, 2007Feb 1, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7897391Jul 23, 2007Mar 1, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7897392Jul 23, 2007Mar 1, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7897393Jul 23, 2007Mar 1, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7897844Jun 28, 2007Mar 1, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7902427Mar 21, 2007Mar 8, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7906706Mar 21, 2007Mar 15, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7919320Jul 12, 2007Apr 5, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7939716Mar 21, 2007May 10, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7960524Mar 22, 2007Jun 14, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US7973149Jul 12, 2007Jul 5, 2011Martek Biosciences CorporationPUFA polyketide synthase systems and uses thereof
US8003772May 16, 2007Aug 23, 2011Martek Biosciences CorporationChimeric PUFA polyketide synthase systems and uses thereof
US8309796Jun 27, 2011Nov 13, 2012Dsm Ip Assets B.V.Chimeric PUFA polyketide synthase systems and uses thereof
US8426686Jun 8, 2010Apr 23, 2013Dsm Ip Assets B.V.Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems
US8829274Feb 13, 2007Sep 9, 2014Dsm Ip Assets B.V.Schizochytrium PKS genes
US8859855Oct 2, 2012Oct 14, 2014Dsm Ip Assets B.V.Chimeric PUFA polyketide synthase systems and uses thereof
US8940884Mar 19, 2010Jan 27, 2015Dsm Ip Assets B.V.Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
WO2007106905A2 *Mar 15, 2007Sep 20, 2007Martek Biosciences CorpPolyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems
Classifications
U.S. Classification800/281, 435/193, 536/23.2, 435/419
International ClassificationC12N15/54, C12N9/10
Cooperative ClassificationC07K2319/00, C12N9/1029
European ClassificationC12N9/10C1